<?xml version="1.0" encoding="ASCII"?><!DOCTYPE article PUBLIC "-//BEILSTEIN-INSTITUT//DTD Journal Article DTD v0.4.4 20130724//EN" "https://www.beilstein-journals.org/bjoc/content/xml/journalarticle.v044.dtd">
<article locale="en" public-id="1860-5397-6-25" publisher="Beilstein-Institut" journal="Beilstein Journal of Organic Chemistry" journal-abbreviated="Beilstein J. Org. Chem." journal-code="bjoc" issn="1860-5397" coden="BJOCBH" year="2010" volume="6" article="25" type="full-research-paper">
<author given-names="A. Sanjeev" last-name="Kumar" affiliations="a1"/>
<author given-names="Samir" last-name="Ghosh" affiliations="a1"/>
<author given-names="G. N." last-name="Mehta" email="drgnmehta@rediffmail.com" affiliations="a1" corresponding-author="yes"/>
<affiliation id="a1" institution-required="yes">Applied Chemistry Department, Sardar Vallabhbhai National Institute of Technology, Surat-395 007, India</affiliation>
<editor first-name="John" middle-names="A" last-name="Porco Jr." role="associate-editor"/>
<submission-date day="10" month="1" year="2010" hour="0" minute="0"/>
<acceptance-date day="25" month="2" year="2010" hour="0" minute="0"/>
<publication-date day="11" month="3" year="2010" hour="0" minute="0"/>
<title>
<chunk>Efficient and improved synthesis of Telmisartan</chunk>
</title>
<keyword>
<chunk>antihypertensive drug</chunk>
</keyword>
<keyword>
<chunk>oxazoline hydrolysis</chunk>
</keyword>
<keyword>
<chunk>Suzuki coupling</chunk>
</keyword>
<keyword>
<chunk>Telmisartan</chunk>
</keyword>
<abstract-section>
<paragraph>
<chunk>An efficient synthesis of the angiotensin II receptor antagonist Telmisartan (</chunk>
<chunk bold="yes">1</chunk>
<chunk>) is presented involving a cross coupling of 4-formylphenylboronic acid </chunk>
<chunk bold="yes">10</chunk>
<chunk> with 2-(2-bromophenyl)-4,4-dimethyl-2-oxazoline (</chunk>
<chunk bold="yes">11</chunk>
<chunk>) as the key step (90% yield). The benzimidazole moiety </chunk>
<chunk bold="yes">15</chunk>
<chunk> was constructed regioselectively via a reductive amination-condensation sequence, replacing the alkylation of the preformed benzimidazole step in the previously published route. This methodology overcomes many of drawbacks associated with previously reported syntheses.</chunk>
</paragraph>
</abstract-section>
<abstract-graphic public-id="1860-5397-6-25-graphical-abstract"/>
<external-link type="doi" public-id="10.3762/bjoc.6.25"/>
<section>
<title>
<chunk>Introduction</chunk>
</title>
<paragraph>
<chunk>Telmisartan (</chunk>
<chunk bold="yes">1</chunk>
<chunk>) is an angiotensin II receptor antagonist useful in the treatment of hypertension, heart diseases, heart attack, and bladder diseases </chunk>
<link target="b1"/>
<link target="b2"/>
<link target="b3"/>
<chunk>. Telmisartan is currently available in the market as an antihypertensive drug </chunk>
<link target="b4"/>
<chunk> under the brand name of Micardis</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk>.</chunk>
</paragraph>
<paragraph>
<chunk>Essential hypertension is a major risk factor in cardiovascular diseases and is responsible for one-third of global deaths. Most antihypertensive drugs interact with the renin-angiotensin system (RAS), which is the central regulator of blood pressure and electrolyte homeostasis. Renin transforms angiotensinogen into the decapeptide angiotensin I, which is converted by the angiotensin conversion enzyme (ACE) into the octapeptide angiotensin II. The latter binds to its angiotensin receptor (AT</chunk>
<chunk subscript="yes">1</chunk>
<chunk>) and, thereby, becomes a powerful vasoconstrictor. In the early 1990s, Merck introduced the non-peptidic orally active angiotensin II receptor antagonist losartan (Lozaar) as the first member of a new class of antihypertensive drugs called sartans, all of which contain a characteristic </chunk>
<chunk italic="yes">ortho</chunk>
<chunk> functionalized biaryl moiety. Telmisartan (</chunk>
<chunk bold="yes">1</chunk>
<chunk>, Boehringer Ingelheim, Micardis</chunk>
<chunk superscript="yes">&#174;</chunk>
<chunk>) (</chunk>
<link target="f1"/>
<chunk>) is an important member of this class of top-selling drugs because it has the strongest binding affinity to the AT</chunk>
<chunk subscript="yes">1</chunk>
<chunk> receptor, an excellent bioavailability, and a once-per-day dosage.</chunk>
</paragraph>
<float target="f1"/>
<paragraph>
<chunk>The first total synthesis of Telmisartan as introduced by Ries et al. (</chunk>
<link target="s1"/>
<chunk>) starts with the acylation of 4-amino-3-methylbenzoic acid methyl ester (</chunk>
<chunk bold="yes">2</chunk>
<chunk>) with butyryl chloride, followed by nitration, reduction of the nitro group, and subsequent cyclization of the resulting amine to the benzimidazole derivative </chunk>
<chunk bold="yes">3</chunk>
<chunk>. After saponification, the free carboxyl group is condensed with </chunk>
<chunk italic="yes">N</chunk>
<chunk>-methyl-1,2-phenylenediamine to afford the bis-benzimidazole </chunk>
<chunk bold="yes">4</chunk>
<chunk>, which is then alkylated with the 4&#8242;-(bromomethyl)-2-biphenylcarboxylic acid </chunk>
<chunk italic="yes">tert</chunk>
<chunk>-butyl ester (</chunk>
<chunk bold="yes">8</chunk>
<chunk>) to give, after hydrolysis of the ester group, Telmisartan (</chunk>
<chunk bold="yes">1</chunk>
<chunk>) in 21% overall yield and with eight steps as the longest sequence </chunk>
<link target="b5"/>
<chunk>.</chunk>
</paragraph>
<paragraph>
<chunk>Several improvements to the above reaction sequence have been reported, e.g., the use of KOH instead of potassium </chunk>
<chunk italic="yes">tert</chunk>
<chunk>-butoxide in the penultimate step and the use of methanolic HCl solution instead of trifluoroacetic acid in the final step </chunk>
<link target="b6"/>
<chunk>. However, the main shortcomings of the synthesis remained, namely, the unsatisfactory regioselectivity in the alkylation of </chunk>
<chunk bold="yes">8</chunk>
<chunk> with </chunk>
<chunk bold="yes">4</chunk>
<chunk> and the intricate synthesis of the biaryl intermediate </chunk>
<chunk bold="yes">7</chunk>
<chunk>. In the original protocol, the latter was synthesized via an Ullmann coupling of the aryl iodides </chunk>
<chunk bold="yes">5</chunk>
<chunk> and </chunk>
<chunk bold="yes">6</chunk>
<chunk> using 5 equiv of copper </chunk>
<link target="b7"/>
<chunk>. Modern syntheses of </chunk>
<chunk bold="yes">7</chunk>
<chunk> involve cross-couplings of sensitive aryl magnesium </chunk>
<link target="b8"/>
<chunk>, zinc </chunk>
<link target="b9"/>
<chunk>, or boron </chunk>
<link target="b10"/>
<link target="b11"/>
<chunk> compounds with alkyl 2-halobenzoates. Since the commercialization of Telmisartan, </chunk>
<chunk bold="yes">7</chunk>
<chunk> has become readily available at low cost, so that most subsequent published procedures start from this compound.</chunk>
</paragraph>
<float target="s1"/>
<paragraph>
<chunk>In designing an alternative synthesis of Telmisartan our goal was to minimize the use of expensive and hazardous metals, circumvent the bromination step, and increase the overall efficiency of the synthesis. This was accomplished by reversing the order of the major bond disconnections. We realized biaryl synthesis and reductive amination are the key steps, and have the potential to overcome both of these weaknesses.</chunk>
</paragraph>
</section>
<section>
<title>
<chunk>Results and Discussion</chunk>
</title>
<paragraph>
<chunk>We identified 4-formylphenylboronic acid (</chunk>
<chunk bold="yes">10</chunk>
<chunk>) and 2-(2-bromophenyl)-4,4-dimethyl-2-oxazoline (</chunk>
<chunk bold="yes">11</chunk>
<chunk>) </chunk>
<link target="b12"/>
<chunk> as the ideal starting materials for the preparation of the key biaryl intermediate. Thus, Suzuki coupling of 2-(2-bromophenyl)-4,4-dimethyl-2-oxazoline with 4-formylphenylboronic acid in presence of aqueous sodium carbonate and tetrakis(triphenylphosphine)palladium(0) in THF solvent gave 2&#8217;-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)biphenyl-4-carbaldehyde (</chunk>
<chunk bold="yes">12</chunk>
<chunk>) in over 90% yield (</chunk>
<link target="s2"/>
<chunk>).</chunk>
</paragraph>
<float target="s2"/>
<paragraph>
<chunk>The reductive amination of the biaryl aldehyde </chunk>
<chunk bold="yes">12</chunk>
<chunk> with amine </chunk>
<chunk bold="yes">13</chunk>
<chunk> (prepared by the literature procedure </chunk>
<link target="b13"/>
<chunk>) was carried out in the presence of </chunk>
<chunk italic="yes">p</chunk>
<chunk>-toluenesulfonic acid in toluene and followed by hydrogenation in methyl alcohol. The resulting amine </chunk>
<chunk bold="yes">14</chunk>
<chunk> was not isolated but cyclized in situ to the </chunk>
<chunk italic="yes">n</chunk>
<chunk>-propyl benzimidazole </chunk>
<chunk bold="yes">15</chunk>
<chunk> in 80% yield in refluxing glacial acetic acid. Finally, cleavage of the oxazoline moiety in </chunk>
<chunk bold="yes">15</chunk>
<chunk> by acid afforded Telmisartan (</chunk>
<chunk bold="yes">1</chunk>
<chunk>) (</chunk>
<link target="s3"/>
<chunk>).</chunk>
</paragraph>
<float target="s3"/>
</section>
<section>
<title>
<chunk>Conclusion</chunk>
</title>
<paragraph>
<chunk>In conclusion, a concise and selective synthesis of the antihypertensive drug Telmisartan has been developed, featuring a Suzuki cross-coupling for the construction of the biaryl moiety and a regiospecific reductive amination-condensation sequence for the synthesis of the central benzimidazole.</chunk>
</paragraph>
</section>
<section>
<title>
<chunk>Experimental</chunk>
</title>
<paragraph>
<chunk>All solvents and reagents were purchased from the commercial suppliers and used without further purification. All non-aqueous reactions were performed in dry glassware under an atmosphere of dry nitrogen. Organic solutions were concentrated under reduced pressure. Thin layer chromatography was performed on Merck precoated Silica-gel 60F</chunk>
<chunk subscript="yes">254</chunk>
<chunk> plates. </chunk>
<chunk superscript="yes">1</chunk>
<chunk>H and </chunk>
<chunk superscript="yes">13</chunk>
<chunk>C NMR spectra were recorded in DMSO-</chunk>
<chunk italic="yes">d</chunk>
<chunk subscript="yes">6</chunk>
<chunk> and CDCl</chunk>
<chunk subscript="yes">3</chunk>
<chunk> using 400 MHz, on a Varian Gemini 400 MHz FT NMR spectrometer. The chemical shifts were reported in &#948; ppm relative to TMS (tetramethylsilane). The IR spectra were recorded in the solid state as KBr dispersion using Perkin Elmer FT-IR spectrophotometer. The mass spectra were recorded on Shimadzu LCMS-QP 800 LC-MS and AB-4000 Q-trap LC-MS/MS. Melting points were obtained by using the open capillary method and are uncorrected.</chunk>
</paragraph>
<paragraph>
<chunk bold="yes">2&#8217;-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)biphenyl-4-carbaldehyde (12):</chunk>
<chunk> To a mixture of 4-formylphenylboronic acid (</chunk>
<chunk bold="yes">10</chunk>
<chunk>) (5.0 g, 0.032 mol) and 2-(2-bromophenyl)-4,4-dimethyl-2-oxazoline (</chunk>
<chunk bold="yes">11</chunk>
<chunk>) (10.1 g, 0.039 mol) in tetrahydrofuran (50.0 mL), 2 M aqueous sodium carbonate solution (20.0 mL) was added at room temperature. The resulting biphasic solution was degassed with nitrogen gas for 20 min. Tetrakis(triphenylphosphine)palladium(0) (0.25 g) was added and heated to reflux (64 &#176;C). The reaction mixture was maintained under reflux for 12 h. After completion of the reaction, the reaction mixture was cooled to 26 &#176;C and saturated ammonium chloride solution (50 mL) and ethyl acetate (50 mL) added. The organic layer was separated, washed twice with water (50.0 mL), dried over sodium sulfate and evaporated under vacuum. The residue was chromatographed on silica gel eluting with hexane/ethyl acetate 80:20 to give the title compound </chunk>
<chunk bold="yes">12</chunk>
<chunk> as an oil (8.0 g, 90%); </chunk>
<chunk superscript="yes">1</chunk>
<chunk>H NMR (400 MHz, DMSO-</chunk>
<chunk italic="yes">d</chunk>
<chunk subscript="yes">6</chunk>
<chunk>) (&#948; ppm): 10.0 (1H, s, -CHO), 7.91 (2H, d, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 8.4 Hz, ArH), 7.73 (1H, d, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 8.4 Hz, ArH), 7.48 (2H, d, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 7.8 Hz, ArH), 7.44&#8211;7.34 (2H, m, ArH), 7.30 (1H, m, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 7.4 Hz, ArH), 3.80 (2H, s, -CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>), 1.12 (6H, s, 2 &#215; -CH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>); </chunk>
<chunk superscript="yes">13</chunk>
<chunk>C NMR (100 MHz, DMSO-</chunk>
<chunk italic="yes">d</chunk>
<chunk subscript="yes">6</chunk>
<chunk>) (&#948; ppm); 28.0, 68.0, 78.9, 128.0, 128.5, 129.5, 129.6, 130.4, 130.5, 131.2, 135.3, 140.2, 147.0, 161.8, 193.2.; MS (</chunk>
<chunk italic="yes">m/z</chunk>
<chunk>): 280 [M</chunk>
<chunk superscript="yes">+</chunk>
<chunk> + 1].</chunk>
</paragraph>
<paragraph>
<chunk bold="yes">3'-{[2'-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)biphenyl-4-yl]methyl}-1,7'-dimethyl-2'-propyl-1</chunk>
<chunk bold="yes" italic="yes">H</chunk>
<chunk bold="yes">,3'</chunk>
<chunk bold="yes" italic="yes">H</chunk>
<chunk bold="yes">-2,5'-bibenzimidazole (15)</chunk>
<chunk>: A mixture of </chunk>
<chunk bold="yes">13</chunk>
<chunk> (4.0 g, 0.01 mol), </chunk>
<chunk bold="yes">12</chunk>
<chunk> (3.5 g, 0.01 mol), and </chunk>
<chunk italic="yes">p</chunk>
<chunk>-TsOH (0.21 g, 0.001 mol) was suspended in toluene (40 mL) under nitrogen, and the mixture refluxed for 16 h and then concentrated. The residue was diluted with methanol (40 mL) and transferred to a stainless steel autoclave. Palladium on charcoal (10%, 1.0 g) was added and the reaction mixture stirred under H</chunk>
<chunk subscript="yes">2</chunk>
<chunk> pressure (7 bar) for 24 h at 60 &#176;C. After cooling to room temperature and filtration, the filter cake was rinsed with ethyl acetate (3 &#215; 50 mL). The filtrate was washed with water, and the aqueous layer basified to pH 10 with aqueous ammonia and extracted with ethyl acetate (2 &#215; 50 mL). The combined organic layers were dried over MgSO</chunk>
<chunk subscript="yes">4</chunk>
<chunk> and concentrated. The crude amine </chunk>
<chunk bold="yes">14</chunk>
<chunk> was diluted with glacial acetic acid (40 mL), the resulting solution refluxed for 2 h and then concentrated. Water (150 mL) was added to residue. The product was extracted twice with ethyl acetate (2 &#215; 50 mL) and evaporated under vacuum at 55 &#176;C. The residue was triturated with </chunk>
<chunk italic="yes">n</chunk>
<chunk>-hexane (40 mL) to yield a solid which was removed by filtration and dried at 50&#8211;55 &#176;C for 3&#8211;4 h to afford </chunk>
<chunk bold="yes">15</chunk>
<chunk> as a white crystalline powder (yield 5.7 g, 80% yield); melting point 191&#8211;193 &#176;C; IR (KBr, cm</chunk>
<chunk superscript="yes">-1</chunk>
<chunk>) 1630 (C=N); HRMS </chunk>
<chunk italic="yes">m/z</chunk>
<chunk> calculated for C</chunk>
<chunk subscript="yes">37</chunk>
<chunk>H</chunk>
<chunk subscript="yes">37</chunk>
<chunk>N</chunk>
<chunk subscript="yes">5</chunk>
<chunk>O &#8211; 568.7225 [M + 1], found &#8211; 568.7222; </chunk>
<chunk superscript="yes">1</chunk>
<chunk>H NMR (400 MHz, CDCl</chunk>
<chunk subscript="yes">3</chunk>
<chunk>) (&#948; ppm): 7.78 (1H, d, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 8.0 Hz, ArH), 7.68 (1H, m, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 8.0 Hz, ArH), 7.47&#8211;7.26 (10H, m, ArH), 7.07 (2H, m, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 8.0 Hz, ArH), 5.45 (2H, s, -CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>), 3.82 (3H, s, -CH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>), 3.58 (2H, s, -CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>), 2.97 (2H, t, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 7.6 Hz, -CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>), 2.74 (3H, s, -CH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>), 1.92 (2H, m , </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 7.6 Hz, -CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>), 1.29 (6H, s, 2 x -CH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>), 1.04 (3H, t, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 7.6 Hz, -CH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>); </chunk>
<chunk superscript="yes">13</chunk>
<chunk>C NMR (100 MHz, CDCl</chunk>
<chunk subscript="yes">3</chunk>
<chunk>) (&#948; ppm): 13.9, 16.7, 21.6, 27.6, 29.6, 31.6, 46.9, 67.2, 79.0, 108.8, 109.2, 119.3, 122.1, 122.2, 123.5, 123.6, 125.6, 127.0, 127.2, 128.8, 129.1, 129.7, 129.9, 130.2, 134.4, 134.8, 136.4, 140.6, 140.8, 142.6, 142.8, 154.2, 156.2, 163.1.</chunk>
</paragraph>
<paragraph>
<chunk bold="yes">4&#8217;-[(1,7&#8217;-dimethyl-2&#8217;-propyl-1</chunk>
<chunk bold="yes" italic="yes">H</chunk>
<chunk bold="yes">,3&#8217;</chunk>
<chunk bold="yes" italic="yes">H</chunk>
<chunk bold="yes">-2,5&#8217;-bibenzimidazol-3&#8217;-yl)methyl]biphenyl -2-carboxylic acid (1)</chunk>
<chunk>: A mixture of </chunk>
<chunk bold="yes">15</chunk>
<chunk> (4.0 g, 0.007 mol) and concentrated hydrochloric acid (40 mL) was heated at reflux (100&#8211;110 &#176;C) for about 30 h. The reaction mass was cooled to 0&#8211;5 &#176;C. Sodium hydroxide solution (20%) was added until the pH of the reaction mixture was 9&#8211;10 and then stirred at room temperature for a further 2 h. The resulting solid was removed by filtration and washed with water (50 mL). The wet cake was dissolved in a mixture of water (60 mL) and acetonitrile (20 mL) and then heated to 60&#8211;65 &#176;C. The pH of the resulting clear solution was adjusted to 5.0&#8211;5.5 with 5% acetic acid, and stirring continued for 2 h. The precipitated solid was filtered and washed with water (50 mL). After drying at 70&#8211;75 &#176;C for 4&#8211;5 h under a vacuum Telmisartan (</chunk>
<chunk bold="yes">1</chunk>
<chunk>) was obtained as a white crystalline powder (yield 2.9 g, 80%); melting point: 260&#8211;262 &#176;C (lit </chunk>
<link target="b6"/>
<chunk> mp 260&#8211;262 &#176;C); IR (KBr, cm</chunk>
<chunk superscript="yes">-1</chunk>
<chunk>) 2300&#8211;3500 (broad), 1680 (C=O); HRMS </chunk>
<chunk italic="yes">m/z</chunk>
<chunk> calculated for C</chunk>
<chunk subscript="yes">33</chunk>
<chunk>H</chunk>
<chunk subscript="yes">30</chunk>
<chunk>N</chunk>
<chunk subscript="yes">4</chunk>
<chunk>O</chunk>
<chunk subscript="yes">2</chunk>
<chunk> &#8211; 515.6169 [M + 1], found &#8211; 515.6192; </chunk>
<chunk superscript="yes">1</chunk>
<chunk>H NMR (400 MHz, CDCl</chunk>
<chunk subscript="yes">3</chunk>
<chunk>) (&#948; ppm): 12.8 (1H, s, -COOH), 8.42 (1H, d, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 8.0 Hz, ArH), 8.02 (1H, d, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 8.0 Hz, ArH), 7.50&#8211;7.26 (8H, m, ArH), 7.20 (2H, d, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 8.0 Hz, ArH), 7.05 (1H, s, ArH), 6.96 (1H, s, ArH), 5.42 (2H, s, -CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>), 3.82 (3H, s, -CH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>), 2.97 (2H, t, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 7.6 Hz, -CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>), 2.74 (3H, s, -CH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>), 1.92 (2H, m, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 7.6 Hz, -CH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>), 1.04 (3H, t, </chunk>
<chunk italic="yes">J</chunk>
<chunk> = 7.6 Hz, -CH</chunk>
<chunk subscript="yes">3</chunk>
<chunk>); </chunk>
<chunk superscript="yes">13</chunk>
<chunk>C NMR (100 MHz, DMSO-</chunk>
<chunk italic="yes">d</chunk>
<chunk subscript="yes">6</chunk>
<chunk>) (&#948; ppm): 13.5, 16.7, 20.6, 27.6, 32.7, 47.1, 51.7, 112.0, 112.7, 114.7, 118.6, 125.3, 125.7, 125.8, 127.0, 127.4, 128.6, 129.3, 130.4, 130.6, 131.5, 132.3, 133.1, 133.2, 133.7, 134.5, 140.2, 140.5, 150.2, 157.3, 168.1.</chunk>
</paragraph>
</section>
<album-graphics>
<graphic public-id="1860-5397-6-25-i1"/>
</album-graphics>
<figures>
<figure id="f1">
<caption>
<paragraph>
<chunk>The angiotensin II receptor antagonist Telmisartan.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-6-25-1"/>
</figure>
</figures>
<schemes>
<scheme id="s1">
<caption>
<paragraph>
<chunk>First literature synthesis of Telmisartan (a) </chunk>
<chunk italic="yes" superscript="yes">n</chunk>
<chunk>PrCOCl, C</chunk>
<chunk subscript="yes">6</chunk>
<chunk>H</chunk>
<chunk subscript="yes">5</chunk>
<chunk>Cl, 100 &#176;C (b) HNO</chunk>
<chunk subscript="yes">3</chunk>
<chunk>/H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>SO</chunk>
<chunk subscript="yes">4</chunk>
<chunk>, 0 &#176;C (c) Pd/C, 5 bar, H</chunk>
<chunk subscript="yes">2,</chunk>
<chunk> MeOH (d) AcOH, 120 &#176;C, yield: 78% (e) NaOH, MeOH/H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O, 100 &#176;C (f) 2-MeNH-C</chunk>
<chunk subscript="yes">6</chunk>
<chunk>H</chunk>
<chunk subscript="yes">4</chunk>
<chunk>-NH</chunk>
<chunk subscript="yes">2</chunk>
<chunk>, PPA, 150 &#176;C, yield: 64% (g) </chunk>
<chunk italic="yes" superscript="yes">t</chunk>
<chunk>BuOK, DMSO, RT (h) TFA, DCM, RT, yield: 42% (i) Cu (5 equiv), 210 &#176;C, (j) HCl, H</chunk>
<chunk subscript="yes">2</chunk>
<chunk>O, 100 &#176;C (k) (COCl)</chunk>
<chunk subscript="yes">2</chunk>
<chunk>, DCM, 0 &#176;C, (l) </chunk>
<chunk italic="yes" superscript="yes">t</chunk>
<chunk>BuOK, THF, RT, yield: 9% (m) NBS, (PhCOO)</chunk>
<chunk subscript="yes">2</chunk>
<chunk>, CCl</chunk>
<chunk subscript="yes">4</chunk>
<chunk>, 76 &#176;C.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-6-25-i1"/>
</scheme>
<scheme id="s2">
<caption>
<paragraph>
<chunk>(a) Pd(PPh</chunk>
<chunk subscript="yes">3</chunk>
<chunk>)</chunk>
<chunk subscript="yes">4</chunk>
<chunk>, aq Na</chunk>
<chunk subscript="yes">2</chunk>
<chunk>CO</chunk>
<chunk subscript="yes">3</chunk>
<chunk>, THF, 12.0 h, 90%.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-6-25-i2"/>
</scheme>
<scheme id="s3">
<caption>
<paragraph>
<chunk>(a) p-TsOH, toluene, 110 &#176;C, 12 h, (b) Pd/C, 7 bar H</chunk>
<chunk subscript="yes">2,</chunk>
<chunk> MeOH, 60 &#176;C, 24 h, 100% (c) AcOH, 120 &#176;C, 2 h, 80% (d) Conc. HCl, 100&#8211;110 &#176;C, 30 h, 80%.</chunk>
</paragraph>
</caption>
<graphic public-id="1860-5397-6-25-i3"/>
</scheme>
</schemes>
<substances>
<substance id="1860-5397-6-25-RMMXLENWKUUMAY-UHFFFAOYSA-N">
<inchi-key>RMMXLENWKUUMAY-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)</inchi>
<smiles>CCCC1=NC2=C(C=C(C=C2C)C3=NC4=C(C=CC=C4)N3C)N1CC5=CC=C(C=C5)C6=C(C=CC=C6)C(=O)O</smiles>
<extended-smiles>C1=CC=C2C(=C1)N=C(N2C)C3=CC4=C(C(=C3)C)N=C(CCC)N4CC5=CC=C(C=C5)C6=CC=CC=C6C(=O)O |(25.42,-38.19,;25.4,-49.88,;35.49,-55.71,;45.57,-49.86,;45.56,-38.12,;35.46,-32.44,;56.68,-34.56,;63.64,-44.06,;56.69,-53.49,;56.55,-65.06,;75.13,-44.01,;80.93,-54.06,;92.42,-54,;98.33,-43.95,;92.34,-33.9,;80.8,-34.01,;98.15,-23.76,;109.59,-46.4,;110.83,-57.85,;120.92,-63.74,;120.93,-75.31,;131.03,-81.12,;100.18,-62.54,;97.79,-73.81,;87.8,-79.58,;77.81,-73.81,;67.81,-79.58,;67.81,-91.12,;77.81,-96.89,;87.8,-91.12,;57.83,-96.88,;47.81,-91.1,;37.8,-96.88,;37.8,-108.45,;47.81,-114.23,;57.83,-108.45,;67.81,-114.21,;67.81,-125.74,;77.79,-108.45,)|</extended-smiles>
<aux-info>AuxInfo=1/1/N:23,20,10,22,33,34,1,2,21,32,35,4,3,26,30,27,29,14,12,24,13,25,28,11,31,36,8,9,17,19,16,6,37,7,15,5,18,38,39/E:(14,15)(16,17)(38,39)/rA:39nCCCCNCNCCCCCCCNCCNCCCCCCCCCCCCCCCCCCCOO/rB:d1;s2;s1;;s5;d6;d4s7;d3s5s8;s5;s6;d11;;s11d13;;s13s15;s12d16;s17;d15s18;s13;s19;s21;s22;s18;s24;d25;s26;d27;s28;s25d29;s28;d31;s32;d33;s34;s31d35;s36;d37;s37;/rC:25,4216,-38,1871,0;25,3995,-49,8762,0;35,4924,-55,7052,0;35,4578,-32,4399,0;56,6936,-53,4882,0;63,6371,-44,0597,0;56,6845,-34,5577,0;45,5619,-38,1176,0;45,5669,-49,8605,0;56,5522,-65,0642,0;75,1343,-44,0097,0;80,9307,-54,0578,0;92,3376,-33,9020,0;80,8014,-34,0123,0;109,5888,-46,3982,0;98,3337,-43,9505,0;92,4180,-54,0039,0;100,1809,-62,5365,0;110,8287,-57,8534,0;98,1473,-23,7629,0;120,9214,-63,7444,0;120,9337,-75,3083,0;131,0262,-81,1196,0;97,7874,-73,8149,0;87,7963,-79,5833,0;77,8053,-73,8149,0;67,8142,-79,5833,0;67,8142,-91,1200,0;77,8053,-96,8883,0;87,7963,-91,1200,0;57,8292,-96,8848,0;47,8133,-91,1021,0;37,7974,-96,8848,0;37,7974,-108,4501,0;47,8133,-114,2328,0;57,8292,-108,4501,0;67,8103,-114,2127,0;67,8103,-125,7379,0;77,7915,-108,4501,0;</aux-info>
<molecular-formula>C33H30N4O2</molecular-formula>
<abbreviations>C(=O)(O)* COOH</abbreviations>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 39 44 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 25.42159 -38.1871 0 0
M  V30 2 C 25.39946 -49.87619 0 0
M  V30 3 C 35.4924 -55.7052 0 0
M  V30 4 C 35.45782 -32.43987 0 0
M  V30 5 N 56.69356 -53.48822 0 0
M  V30 6 C 63.6371 -44.05972 0 0
M  V30 7 N 56.68452 -34.55772 0 0
M  V30 8 C 45.56194 -38.11755 0 0
M  V30 9 C 45.56694 -49.86049 0 0
M  V30 10 C 56.5522 -65.06419 0 0
M  V30 11 C 75.13434 -44.0097 0 0
M  V30 12 C 80.93068 -54.05779 0 0
M  V30 13 C 92.33757 -33.90198 0 0
M  V30 14 C 80.80136 -34.01234 0 0
M  V30 15 N 109.58879 -46.39819 0 0
M  V30 16 C 98.33371 -43.95052 0 0
M  V30 17 C 92.41795 -54.00392 0 0
M  V30 18 N 100.18092 -62.53647 0 0
M  V30 19 C 110.82872 -57.85336 0 0
M  V30 20 C 98.14734 -23.76288 0 0
M  V30 21 C 120.92139 -63.74437 0 0
M  V30 22 C 120.93365 -75.30833 0 0
M  V30 23 C 131.02621 -81.11961 0 0
M  V30 24 C 97.7874 -73.8149 0 0
M  V30 25 C 87.79631 -79.58325 0 0
M  V30 26 C 77.80525 -73.8149 0 0
M  V30 27 C 67.81416 -79.58325 0 0
M  V30 28 C 67.81416 -91.11996 0 0
M  V30 29 C 77.80525 -96.88831 0 0
M  V30 30 C 87.79631 -91.11996 0 0
M  V30 31 C 57.82922 -96.88475 0 0
M  V30 32 C 47.81332 -91.10208 0 0
M  V30 33 C 37.79744 -96.88475 0 0
M  V30 34 C 37.79744 -108.4501 0 0
M  V30 35 C 47.81332 -114.23279 0 0
M  V30 36 C 57.82922 -108.4501 0 0
M  V30 37 C 67.81033 -114.21271 0 0
M  V30 38 O 67.81033 -125.73793 0 0
M  V30 39 O 77.79147 -108.4501 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 9
M  V30 4 2 8 4
M  V30 5 1 4 1
M  V30 6 1 8 9
M  V30 7 2 6 7
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 9 5
M  V30 11 1 5 10
M  V30 12 1 6 11
M  V30 13 2 11 12
M  V30 14 1 12 17
M  V30 15 1 16 13
M  V30 16 2 13 14
M  V30 17 1 14 11
M  V30 18 2 16 17
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 19 15
M  V30 22 1 13 20
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 18 19
M  V30 27 1 18 24
M  V30 28 1 24 25
M  V30 29 2 25 26
M  V30 30 1 26 27
M  V30 31 2 27 28
M  V30 32 1 28 29
M  V30 33 2 29 30
M  V30 34 1 30 25
M  V30 35 1 28 31
M  V30 36 2 31 32
M  V30 37 1 32 33
M  V30 38 2 33 34
M  V30 39 1 34 35
M  V30 40 2 35 36
M  V30 41 1 36 31
M  V30 42 2 37 38
M  V30 43 1 37 39
M  V30 44 1 36 37
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-1" left="25.144058" right="131.15352" top="23.636047" bottom="117.28772"/>
<backref ref="1860-5397-6-25-i1" left="155.65338" right="261.14508" top="217.5206" bottom="310.7289"/>
<backref ref="1860-5397-6-25-i3" left="276.7631" right="382.99542" top="192.49327" bottom="286.3465"/>
</substance>
<substance id="1860-5397-6-25-BXXLTVBTDZXPTN-UHFFFAOYSA-N">
<inchi-key>BXXLTVBTDZXPTN-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C8H7IO2/c1-11-8(10)6-4-2-3-5-7(6)9/h2-5H,1H3</inchi>
<smiles>COC(=O)C1=C(C=CC=C1)I</smiles>
<extended-smiles>C1=CC=CC(=C1C(=O)OC)I |(24.11,-159.72,;24.11,-171.22,;34.08,-176.98,;44.04,-171.22,;44.04,-159.72,;34.08,-153.96,;34.08,-142.49,;24.15,-136.76,;44.01,-136.76,;44.01,-125.29,;53.98,-153.98,)|</extended-smiles>
<aux-info>AuxInfo=1/0/N:11,2,3,1,4,6,5,7,8,9,10/rA:11nCCCCCCCIOOC/rB:d1;s2;d3;s4;s1d5;s6;s5;d7;s7;s10;/rC:24,1109,-159,7157,0;24,1109,-171,2244,0;34,0777,-176,9787,0;44,0444,-171,2244,0;44,0444,-159,7157,0;34,0777,-153,9614,0;34,0777,-142,4927,0;53,9766,-153,9814,0;24,1455,-136,7583,0;44,0099,-136,7583,0;44,0099,-125,2896,0;</aux-info>
<molecular-formula>C8H7IO2</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 24.11087 -159.71573 0 0
M  V30 2 C 24.11087 -171.22438 0 0
M  V30 3 C 34.07765 -176.97871 0 0
M  V30 4 C 44.04445 -171.22438 0 0
M  V30 5 C 44.04445 -159.71573 0 0
M  V30 6 C 34.07765 -153.9614 0 0
M  V30 7 C 34.07765 -142.49266 0 0
M  V30 8 I 53.97664 -153.98137 0 0
M  V30 9 O 24.14546 -136.75832 0 0
M  V30 10 O 44.00986 -136.75832 0 0
M  V30 11 C 44.00986 -125.28961 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 4
M  V30 4 1 4 5
M  V30 5 2 5 6
M  V30 6 1 6 1
M  V30 7 1 6 7
M  V30 8 1 5 8
M  V30 9 2 7 9
M  V30 10 1 7 10
M  V30 11 1 10 11
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i1" left="21.020462" right="55.05165" top="125.28961" bottom="177.2733"/>
</substance>
<substance id="1860-5397-6-25-DEFDQXCQBZEOGY-UHFFFAOYSA-N">
<inchi-key>DEFDQXCQBZEOGY-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C13H16N2O2/c1-4-5-11-14-10-7-9(13(16)17-3)6-8(2)12(10)15-11/h6-7H,4-5H2,1-3H3,(H,14,15)</inchi>
<smiles>CCCC1=NC2=C(C=C(C=C2C)C(=O)OC)N1</smiles>
<extended-smiles>C1=C(C=C2C(=C1C)N=C(N2)CCC)C(OC)=O |(169.63,-40.68,;169.61,-52.23,;179.55,-57.98,;189.55,-52.19,;189.47,-40.61,;179.52,-34.93,;179.47,-23.44,;200.46,-36.96,;207.33,-46.28,;200.59,-55.69,;218.76,-46.27,;226.82,-38.13,;238.32,-38.13,;159.65,-57.96,;149.7,-52.2,;139.76,-57.91,;159.63,-69.45,)|</extended-smiles>
<aux-info>AuxInfo=1/1/N:16,8,17,15,14,1,3,4,2,13,10,12,5,9,11,7,6/rA:17nCCCCCOOCNCNCCCCCC/rB:d1;s2;s1;s2;s5;d5;s4;;s9;d10;d4s11;d3s9s12;s10;s14;s15;s6;/rC:169,6322,-40,6841,0;169,6101,-52,2252,0;179,5535,-57,9802,0;179,5189,-34,9310,0;159,6459,-57,9582,0;149,6988,-52,1954,0;159,6287,-69,4540,0;179,4716,-23,4354,0;200,5880,-55,6917,0;207,3285,-46,2794,0;200,4586,-36,9610,0;189,4734,-40,6144,0;189,5530,-52,1913,0;218,7562,-46,2730,0;226,8193,-38,1302,0;238,3150,-38,1302,0;139,7581,-57,9149,0;</aux-info>
<molecular-formula>C13H16N2O2</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 17 18 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 169.6322 -40.68407 0 0
M  V30 2 C 169.61009 -52.22522 0 0
M  V30 3 C 179.5535 -57.98024 0 0
M  V30 4 C 179.51891 -34.93103 0 0
M  V30 5 C 159.64586 -57.95822 0 0
M  V30 6 O 149.69881 -52.19545 0 0
M  V30 7 O 159.62868 -69.45403 0 0
M  V30 8 C 179.47162 -23.43536 0 0
M  V30 9 N 200.58801 -55.6917 0 0
M  V30 10 C 207.32849 -46.27943 0 0
M  V30 11 N 200.45863 -36.96097 0 0
M  V30 12 C 189.47345 -40.61444 0 0
M  V30 13 C 189.55299 -52.19127 0 0
M  V30 14 C 218.75623 -46.27304 0 0
M  V30 15 C 226.81926 -38.13019 0 0
M  V30 16 C 238.31502 -38.13019 0 0
M  V30 17 C 139.75806 -57.91493 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 13
M  V30 4 2 12 4
M  V30 5 1 4 1
M  V30 6 1 2 5
M  V30 7 1 5 6
M  V30 8 2 5 7
M  V30 9 1 4 8
M  V30 10 1 12 13
M  V30 11 2 10 11
M  V30 12 1 9 10
M  V30 13 1 11 12
M  V30 14 1 13 9
M  V30 15 1 10 14
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 6 17
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i1" left="139.63083" right="238.31502" top="23.43431" bottom="72.52902"/>
</substance>
<substance id="1860-5397-6-25-ILXRSCZVHSZGCS-UHFFFAOYSA-N">
<inchi-key>ILXRSCZVHSZGCS-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C19H20N4/c1-4-7-17-20-15-11-13(10-12(2)18(15)22-17)19-21-14-8-5-6-9-16(14)23(19)3/h5-6,8-11H,4,7H2,1-3H3,(H,20,22)</inchi>
<smiles>CCCC1=NC2=C(C=C(C=C2C)C3=NC4=C(C=CC=C4)N3C)N1</smiles>
<extended-smiles>C1=CC=C2C(=C1)N=C(N2C)C3=CC4=C(C(=C3)C)N=C(CCC)N4 |(298.33,-41.6,;298.31,-53.22,;308.34,-58.97,;318.34,-53.2,;318.34,-41.53,;308.3,-35.84,;329.39,-37.96,;336.27,-47.39,;329.4,-56.75,;329.26,-68.26,;347.7,-47.34,;353.5,-57.32,;364.92,-57.27,;370.76,-47.29,;364.84,-37.31,;353.37,-37.42,;370.57,-27.24,;381.95,-49.74,;383.19,-61.12,;393.21,-66.94,;393.22,-78.44,;403.25,-84.25,;372.61,-65.81,)|</extended-smiles>
<aux-info>AuxInfo=1/1/N:23,20,10,22,1,2,21,4,3,14,12,13,11,8,17,9,19,16,6,18,7,15,5/rA:23nCCCCNCNCCCCCCCNCCNCCCCC/rB:d1;s2;s1;;s5;d6;d4s7;d3s5s8;s5;s6;d11;;s11d13;;s13s15;s12d16;s17;d15s18;s13;s19;s21;s22;/rC:298,3349,-41,5961,0;298,3128,-53,2171,0;308,3360,-58,9721,0;308,3014,-35,8431,0;329,3988,-56,7529,0;336,2695,-47,3948,0;329,3898,-37,9631,0;318,3358,-41,5265,0;318,3408,-53,2014,0;329,2573,-68,2607,0;347,6984,-47,3447,0;353,5005,-57,3230,0;364,8391,-37,3067,0;353,3712,-37,4171,0;381,9480,-49,7356,0;370,7614,-47,2855,0;364,9195,-57,2691,0;372,6105,-65,8102,0;383,1892,-61,1224,0;370,5748,-27,2372,0;393,2121,-66,9395,0;393,2244,-78,4353,0;403,2473,-84,2524,0;</aux-info>
<molecular-formula>C19H20N4</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 23 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 298.3349 -41.5961 0 0
M  V30 2 C 298.31277 -53.21707 0 0
M  V30 3 C 308.336 -58.97211 0 0
M  V30 4 C 308.30142 -35.84309 0 0
M  V30 5 N 329.3988 -56.75288 0 0
M  V30 6 C 336.26947 -47.39478 0 0
M  V30 7 N 329.38977 -37.96306 0 0
M  V30 8 C 318.33582 -41.52646 0 0
M  V30 9 C 318.34082 -53.20137 0 0
M  V30 10 C 329.25726 -68.26068 0 0
M  V30 11 C 347.69843 -47.34473 0 0
M  V30 12 C 353.50055 -57.323 0 0
M  V30 13 C 364.83908 -37.30669 0 0
M  V30 14 C 353.37115 -37.41711 0 0
M  V30 15 N 381.948 -49.7356 0 0
M  V30 16 C 370.76141 -47.28548 0 0
M  V30 17 C 364.91949 -57.26912 0 0
M  V30 18 N 372.6105 -65.81024 0 0
M  V30 19 C 383.18918 -61.12242 0 0
M  V30 20 C 370.57483 -27.23723 0 0
M  V30 21 C 393.21207 -66.9395 0 0
M  V30 22 C 393.22437 -78.43526 0 0
M  V30 23 C 403.24725 -84.25237 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 9
M  V30 4 2 8 4
M  V30 5 1 4 1
M  V30 6 1 8 9
M  V30 7 2 6 7
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 9 5
M  V30 11 1 5 10
M  V30 12 1 6 11
M  V30 13 2 11 12
M  V30 14 1 12 17
M  V30 15 1 16 13
M  V30 16 2 13 14
M  V30 17 1 14 11
M  V30 18 2 16 17
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 19 15
M  V30 22 1 13 20
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 18 19
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i1" left="298.05737" right="403.3753" top="27.110962" bottom="84.47302"/>
</substance>
<substance id="1860-5397-6-25-JSCFLEBEWCTASN-UHFFFAOYSA-N">
<inchi-key>JSCFLEBEWCTASN-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C37H38N4O2/c1-7-12-33-39-34-24(2)21-27(35-38-30-15-10-11-16-31(30)40(35)6)22-32(34)41(33)23-25-17-19-26(20-18-25)28-13-8-9-14-29(28)36(42)43-37(3,4)5/h8-11,13-22H,7,12,23H2,1-6H3</inchi>
<smiles>CCCC1=NC2=C(C=C(C=C2C)C3=NC4=C(C=CC=C4)N3C)N1CC5=CC=C(C=C5)C6=C(C=CC=C6)C(=O)OC(C)(C)C</smiles>
<extended-smiles>C1=CC=C2C(=C1)N=C(N2C)C3=CC4=C(C(=C3)C)N=C(CCC)N4CC5=CC=C(C=C5)C6=CC=CC=C6C(=O)OC(C)(C)C |(309.43,-232.48,;309.4,-244.11,;319.45,-249.91,;329.47,-244.1,;329.47,-232.41,;319.41,-226.76,;340.54,-228.87,;347.45,-238.33,;340.54,-247.71,;340.4,-259.23,;358.89,-238.28,;364.66,-248.28,;376.09,-248.22,;381.98,-238.22,;376.01,-228.22,;364.53,-228.33,;381.79,-218.13,;393.18,-240.65,;394.41,-252.05,;404.46,-257.91,;404.47,-269.42,;414.51,-275.2,;383.82,-256.71,;381.44,-267.94,;371.49,-273.68,;361.55,-267.94,;351.61,-273.68,;351.61,-285.16,;361.55,-290.9,;371.49,-285.16,;341.67,-290.89,;331.71,-285.14,;321.74,-290.89,;321.74,-302.4,;331.71,-308.16,;341.67,-302.4,;351.61,-308.14,;361.54,-302.4,;351.61,-319.6,;361.54,-325.34,;361.54,-336.81,;371.47,-319.6,;371.51,-331.09,)|</extended-smiles>
<aux-info>AuxInfo=1/0/N:23,20,41,42,43,10,22,33,34,1,2,21,32,35,4,3,26,30,27,29,14,12,24,13,25,28,11,31,36,8,9,17,19,16,6,37,40,7,15,5,18,38,39/E:(3,4,5)(17,18)(19,20)/rA:43nCCCCNCNCCCCCCCNCCNCCCCCCCCCCCCCCCCCCCOOCCCC/rB:d1;s2;s1;;s5;d6;d4s7;d3s5s8;s5;s6;d11;;s11d13;;s13s15;s12d16;s17;d15s18;s13;s19;s21;s22;s18;s24;d25;s26;d27;s28;s25d29;s28;d31;s32;d33;s34;s31d35;s36;d37;s37;s39;s40;s40;s40;/rC:309,4254,-232,4826,0;309,4034,-244,1144,0;319,4469,-249,9148,0;319,4125,-226,7635,0;340,5441,-247,7087,0;347,4536,-238,3264,0;340,5351,-228,8710,0;329,4670,-232,4133,0;329,4720,-244,0987,0;340,4034,-259,2279,0;358,8945,-238,2766,0;364,6624,-248,2754,0;376,0134,-228,2184,0;364,5338,-228,3282,0;393,1801,-240,6534,0;381,9801,-238,2177,0;376,0934,-248,2218,0;383,8183,-256,7126,0;394,4139,-252,0524,0;381,7947,-218,1290,0;404,4571,-257,9146,0;404,4693,-269,4218,0;414,5124,-275,2046,0;381,4365,-267,9357,0;371,4944,-273,6758,0;361,5523,-267,9357,0;351,6102,-273,6758,0;351,6102,-285,1559,0;361,5523,-290,8960,0;371,4944,-285,1559,0;341,6742,-290,8925,0;331,7074,-285,1382,0;321,7406,-290,8925,0;321,7406,-302,4012,0;331,7074,-308,1555,0;341,6742,-302,4012,0;351,6064,-308,1355,0;361,5386,-302,4012,0;351,6064,-319,6042,0;361,5386,-325,3386,0;361,5386,-336,8073,0;371,4708,-319,6042,0;371,5054,-331,0929,0;</aux-info>
<molecular-formula>C37H38N4O2</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 43 48 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 309.42542 -232.48256 0 0
M  V30 2 C 309.40338 -244.11436 0 0
M  V30 3 C 319.44687 -249.91478 0 0
M  V30 4 C 319.41248 -226.76349 0 0
M  V30 5 N 340.54413 -247.70866 0 0
M  V30 6 C 347.45361 -238.32639 0 0
M  V30 7 N 340.5351 -228.87096 0 0
M  V30 8 C 329.46704 -232.41335 0 0
M  V30 9 C 329.47205 -244.09872 0 0
M  V30 10 C 340.40344 -259.22791 0 0
M  V30 11 C 358.8945 -238.27661 0 0
M  V30 12 C 364.66241 -248.27544 0 0
M  V30 13 C 376.01337 -228.21844 0 0
M  V30 14 C 364.53375 -228.32825 0 0
M  V30 15 N 393.18005 -240.6534 0 0
M  V30 16 C 381.98013 -238.21773 0 0
M  V30 17 C 376.09338 -248.22185 0 0
M  V30 18 N 383.8183 -256.71255 0 0
M  V30 19 C 394.41391 -252.05241 0 0
M  V30 20 C 381.79468 -218.12903 0 0
M  V30 21 C 404.45709 -257.91455 0 0
M  V30 22 C 404.4693 -269.42181 0 0
M  V30 23 C 414.51239 -275.20462 0 0
M  V30 24 C 381.43652 -267.93573 0 0
M  V30 25 C 371.49442 -273.67578 0 0
M  V30 26 C 361.55231 -267.93573 0 0
M  V30 27 C 351.6102 -273.67578 0 0
M  V30 28 C 351.6102 -285.15594 0 0
M  V30 29 C 361.55231 -290.89603 0 0
M  V30 30 C 371.49442 -285.15594 0 0
M  V30 31 C 341.67419 -290.89252 0 0
M  V30 32 C 331.7074 -285.13818 0 0
M  V30 33 C 321.7406 -290.89252 0 0
M  V30 34 C 321.7406 -302.40118 0 0
M  V30 35 C 331.7074 -308.15552 0 0
M  V30 36 C 341.67419 -302.40118 0 0
M  V30 37 C 351.60638 -308.1355 0 0
M  V30 38 O 361.53857 -302.40115 0 0
M  V30 39 O 351.60641 -319.60422 0 0
M  V30 40 C 361.53857 -325.33856 0 0
M  V30 41 C 361.5386 -336.80725 0 0
M  V30 42 C 371.47076 -319.60419 0 0
M  V30 43 C 371.50537 -331.0929 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 9
M  V30 4 2 8 4
M  V30 5 1 4 1
M  V30 6 1 8 9
M  V30 7 2 6 7
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 9 5
M  V30 11 1 5 10
M  V30 12 1 6 11
M  V30 13 2 11 12
M  V30 14 1 12 17
M  V30 15 1 16 13
M  V30 16 2 13 14
M  V30 17 1 14 11
M  V30 18 2 16 17
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 19 15
M  V30 22 1 13 20
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 18 19
M  V30 27 1 18 24
M  V30 28 1 24 25
M  V30 29 2 25 26
M  V30 30 1 26 27
M  V30 31 2 27 28
M  V30 32 1 28 29
M  V30 33 2 29 30
M  V30 34 1 30 25
M  V30 35 1 28 31
M  V30 36 2 31 32
M  V30 37 1 32 33
M  V30 38 2 33 34
M  V30 39 1 34 35
M  V30 40 2 35 36
M  V30 41 1 36 31
M  V30 42 1 36 37
M  V30 43 2 37 38
M  V30 44 1 37 39
M  V30 45 1 39 40
M  V30 46 1 40 41
M  V30 47 1 40 42
M  V30 48 1 40 43
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i1" left="309.148" right="414.6397" top="218.0022" bottom="336.80725"/>
</substance>
<substance id="1860-5397-6-25-OWEDFWZJRNPJIV-UHFFFAOYSA-N">
<inchi-key>OWEDFWZJRNPJIV-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C18H20O2/c1-13-9-11-14(12-10-13)15-7-5-6-8-16(15)17(19)20-18(2,3)4/h5-12H,1-4H3</inchi>
<smiles>CC1=CC=C(C=C1)C2=C(C=CC=C2)C(=O)OC(C)(C)C</smiles>
<extended-smiles>C1=CC(=CC=C1C)C2=CC=CC=C2C(=O)OC(C)(C)C |(176.29,-126.28,;176.27,-137.98,;186.21,-143.74,;196.35,-137.97,;196.29,-126.21,;186.18,-120.45,;186.13,-108.87,;186.21,-155.3,;176.26,-161.09,;176.25,-172.65,;186.2,-178.41,;196.35,-172.6,;196.31,-161.06,;206.21,-155.21,;206.1,-143.6,;216.16,-161.01,;226.14,-155.1,;231.8,-145.04,;234.2,-163.24,;237.71,-155.1,)|</extended-smiles>
<aux-info>AuxInfo=1/0/N:7,18,19,20,10,11,9,12,1,5,2,4,6,3,8,13,14,17,15,16/E:(2,3,4)(9,10)(11,12)/rA:20nCCCCCCCCCCCCCCOOCCCC/rB:d1;s2;d3;s4;s1d5;s6;s3;d8;s9;d10;s11;s8d12;s13;d14;s14;s16;s17;s17;s17;/rC:176,2931,-126,2792,0;176,2710,-137,9801,0;186,2144,-143,7351,0;196,3488,-137,9709,0;196,2940,-126,2096,0;186,1798,-120,4464,0;186,1325,-108,8709,0;186,2105,-155,3037,0;176,2581,-161,0880,0;176,2494,-172,6459,0;186,2045,-178,4052,0;196,3487,-172,6024,0;196,3084,-161,0635,0;206,2096,-155,2150,0;206,0978,-143,6035,0;216,1566,-161,0069,0;226,1356,-155,0993,0;231,8037,-145,0405,0;234,1986,-163,2421,0;237,7113,-155,0993,0;</aux-info>
<molecular-formula>C18H20O2</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 20 21 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 176.29311 -126.27924 0 0
M  V30 2 C 176.27101 -137.98007 0 0
M  V30 3 C 186.21442 -143.73509 0 0
M  V30 4 C 196.34875 -137.9709 0 0
M  V30 5 C 196.29402 -126.20961 0 0
M  V30 6 C 186.17982 -120.44638 0 0
M  V30 7 C 186.13251 -108.87086 0 0
M  V30 8 C 186.21054 -155.30367 0 0
M  V30 9 C 176.25815 -161.08804 0 0
M  V30 10 C 176.2494 -172.64592 0 0
M  V30 11 C 186.20453 -178.40518 0 0
M  V30 12 C 196.34872 -172.60243 0 0
M  V30 13 C 196.30838 -161.06351 0 0
M  V30 14 C 206.20963 -155.21497 0 0
M  V30 15 O 206.09784 -143.6035 0 0
M  V30 16 O 216.15665 -161.00685 0 0
M  V30 17 C 226.13564 -155.09927 0 0
M  V30 18 C 231.80368 -145.04047 0 0
M  V30 19 C 234.19864 -163.24213 0 0
M  V30 20 C 237.71126 -155.09927 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 4
M  V30 4 1 4 5
M  V30 5 2 5 6
M  V30 6 1 6 1
M  V30 7 1 6 7
M  V30 8 1 3 8
M  V30 9 2 8 9
M  V30 10 1 9 10
M  V30 11 2 10 11
M  V30 12 1 11 12
M  V30 13 2 12 13
M  V30 14 1 13 8
M  V30 15 1 13 14
M  V30 16 2 14 15
M  V30 17 1 14 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 17 19
M  V30 21 1 17 20
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i1" left="175.99417" right="237.71126" top="108.86983" bottom="178.69951"/>
</substance>
<substance id="1860-5397-6-25-UDHAWRUAECEBHC-UHFFFAOYSA-N">
<inchi-key>UDHAWRUAECEBHC-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C7H7I/c1-6-2-4-7(8)5-3-6/h2-5H,1H3</inchi>
<smiles>CC1=CC=C(C=C1)I</smiles>
<extended-smiles>C1=C(C=CC(=C1)I)C |(84.65,-153.12,;84.65,-164.63,;94.62,-170.39,;104.58,-164.63,;104.58,-153.12,;94.62,-147.37,;114.52,-147.39,;74.72,-170.37,)|</extended-smiles>
<aux-info>AuxInfo=1/0/N:8,1,3,6,4,2,5,7/E:(2,3)(4,5)/rA:8nCCCCCCIC/rB:d1;s2;d3;s4;s1d5;s5;s2;/rC:84,6513,-153,1222,0;84,6513,-164,6309,0;94,6180,-170,3852,0;104,5848,-164,6309,0;104,5848,-153,1222,0;94,6180,-147,3679,0;114,5170,-147,3878,0;74,7191,-170,3652,0;</aux-info>
<molecular-formula>C7H7I</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 8 8 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 84.65126 -153.12221 0 0
M  V30 2 C 84.65126 -164.63087 0 0
M  V30 3 C 94.61804 -170.38519 0 0
M  V30 4 C 104.58484 -164.63087 0 0
M  V30 5 C 104.58484 -153.12221 0 0
M  V30 6 C 94.61804 -147.36787 0 0
M  V30 7 I 114.51703 -147.38785 0 0
M  V30 8 C 74.71906 -170.36522 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 4
M  V30 4 1 4 5
M  V30 5 2 5 6
M  V30 6 1 6 1
M  V30 7 1 5 7
M  V30 8 1 2 8
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i1" left="74.59149" right="115.59204" top="143.61285" bottom="170.67978"/>
</substance>
<substance id="1860-5397-6-25-YHXCWNQNVMAENQ-UHFFFAOYSA-N">
<inchi-key>YHXCWNQNVMAENQ-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C18H19BrO2/c1-18(2,3)21-17(20)16-7-5-4-6-15(16)14-10-8-13(12-19)9-11-14/h4-11H,12H2,1-3H3</inchi>
<smiles>CC(C)(C)OC(=O)C1=C(C=CC=C1)C2=CC=C(C=C2)CBr</smiles>
<extended-smiles>C1=CC(=CC=C1CBr)C2=CC=CC=C2C(=O)OC(C)(C)C |(287.83,-126.97,;287.81,-138.67,;297.75,-144.42,;307.88,-138.66,;307.83,-126.9,;297.72,-121.13,;297.67,-109.56,;305.82,-101.42,;297.75,-155.99,;287.79,-161.77,;287.78,-173.33,;297.74,-179.09,;307.88,-173.29,;307.84,-161.75,;317.74,-155.9,;317.63,-144.29,;327.69,-161.69,;337.67,-155.79,;343.34,-145.73,;345.73,-163.93,;349.25,-155.79,)|</extended-smiles>
<aux-info>AuxInfo=1/0/N:19,20,21,11,12,10,13,1,5,2,4,7,6,3,9,14,15,18,8,16,17/E:(1,2,3)(8,9)(10,11)/rA:21nCCCCCCCBrCCCCCCCOOCCCC/rB:d1;s2;d3;s4;s1d5;s6;s7;s3;d9;s10;d11;s12;s9d13;s14;d15;s15;s17;s18;s18;s18;/rC:287,8283,-126,9662,0;287,8062,-138,6670,0;297,7496,-144,4220,0;307,8840,-138,6579,0;307,8292,-126,8966,0;297,7150,-121,1333,0;297,6677,-109,5578,0;305,8179,-101,4207,0;297,7458,-155,9906,0;287,7933,-161,7750,0;287,7846,-173,3329,0;297,7397,-179,0921,0;307,8839,-173,2894,0;307,8436,-161,7505,0;317,7448,-155,9019,0;317,6331,-144,2904,0;327,6918,-161,6938,0;337,6708,-155,7862,0;343,3389,-145,7274,0;345,7339,-163,9291,0;349,2465,-155,7862,0;</aux-info>
<molecular-formula>C18H19BrO2</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 22 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 287.82831 -126.9662 0 0
M  V30 2 C 287.80621 -138.66701 0 0
M  V30 3 C 297.74963 -144.42204 0 0
M  V30 4 C 307.88397 -138.65785 0 0
M  V30 5 C 307.82922 -126.89658 0 0
M  V30 6 C 297.71503 -121.13332 0 0
M  V30 7 C 297.66769 -109.55782 0 0
M  V30 8 Br 305.81793 -101.42075 0 0
M  V30 9 C 297.74576 -155.99062 0 0
M  V30 10 C 287.79333 -161.77498 0 0
M  V30 11 C 287.78461 -173.33286 0 0
M  V30 12 C 297.73975 -179.09215 0 0
M  V30 13 C 307.88391 -173.2894 0 0
M  V30 14 C 307.84357 -161.75046 0 0
M  V30 15 C 317.74481 -155.90193 0 0
M  V30 16 O 317.63306 -144.29044 0 0
M  V30 17 O 327.69183 -161.69379 0 0
M  V30 18 C 337.67084 -155.78624 0 0
M  V30 19 C 343.3389 -145.72742 0 0
M  V30 20 C 345.73386 -163.92906 0 0
M  V30 21 C 349.24646 -155.78624 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 4
M  V30 4 1 4 5
M  V30 5 2 5 6
M  V30 6 1 6 1
M  V30 7 1 6 7
M  V30 8 1 7 8
M  V30 9 1 3 9
M  V30 10 2 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 2 13 14
M  V30 15 1 14 9
M  V30 16 1 14 15
M  V30 17 2 15 16
M  V30 18 1 15 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 1 18 20
M  V30 22 1 18 21
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i1" left="287.5294" right="349.24646" top="97.64574" bottom="179.38646"/>
</substance>
<substance id="1860-5397-6-25-ZHIPSMIKSRYZFV-UHFFFAOYSA-N">
<inchi-key>ZHIPSMIKSRYZFV-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C9H11NO2/c1-6-5-7(9(11)12-2)3-4-8(6)10/h3-5H,10H2,1-2H3</inchi>
<smiles>CC1=CC(=CC=C1N)C(=O)OC</smiles>
<extended-smiles>C1=C(C=CC(=C1C)N)C(=O)OC |(45.09,-41.63,;45.09,-53.14,;55.06,-58.89,;65.02,-53.14,;65.02,-41.63,;55.06,-35.88,;55.06,-24.41,;74.96,-35.9,;35.16,-58.88,;35.16,-70.34,;25.23,-53.14,;15.26,-58.89,)|</extended-smiles>
<aux-info>AuxInfo=1/0/N:9,12,3,4,1,6,2,5,7,8,10,11/rA:12nCCCCCCCNCOOC/rB:d1;s2;d3;s4;s1d5;s2;s5;s6;d7;s7;s11;/rC:45,0902,-41,6320,0;45,0902,-53,1407,0;55,0570,-58,8950,0;65,0238,-53,1407,0;65,0238,-41,6320,0;55,0570,-35,8777,0;35,1580,-58,8750,0;74,9560,-35,8976,0;55,0570,-24,4089,0;35,1580,-70,3437,0;25,2258,-53,1407,0;15,2590,-58,8950,0;</aux-info>
<molecular-formula>C9H11NO2</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 12 12 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 45.09021 -41.63199 0 0
M  V30 2 C 45.09021 -53.14066 0 0
M  V30 3 C 55.05701 -58.89499 0 0
M  V30 4 C 65.02379 -53.14066 0 0
M  V30 5 C 65.02379 -41.63199 0 0
M  V30 6 C 55.05701 -35.87766 0 0
M  V30 7 C 35.158 -58.875 0 0
M  V30 8 N 74.95598 -35.89763 0 0
M  V30 9 C 55.05701 -24.40894 0 0
M  V30 10 O 35.158 -70.3437 0 0
M  V30 11 O 25.22581 -53.14066 0 0
M  V30 12 C 15.25903 -58.89499 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 4
M  V30 4 1 4 5
M  V30 5 2 5 6
M  V30 6 1 6 1
M  V30 7 1 2 7
M  V30 8 1 5 8
M  V30 9 1 6 9
M  V30 10 2 7 10
M  V30 11 1 7 11
M  V30 12 1 11 12
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i1" left="15.13147" right="86.88098" top="24.408936" bottom="73.41872"/>
</substance>
<substance id="1860-5397-6-25-DRCMNHQVZIYACF-UHFFFAOYSA-N">
<inchi-key>DRCMNHQVZIYACF-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C18H17NO2/c1-18(2)12-21-17(19-18)16-6-4-3-5-15(16)14-9-7-13(11-20)8-10-14/h3-11H,12H2,1-2H3</inchi>
<smiles>CC1(C)COC(=N1)C2=C(C=CC=C2)C3=CC=C(C=C3)C=O</smiles>
<extended-smiles>C1=CC(=CC=C1C=O)C2=CC=CC=C2C=3OCC(N3)(C)C |(149.76,-63.52,;149.74,-75.19,;159.66,-81.01,;169.68,-75.18,;169.63,-63.45,;159.62,-57.78,;164.55,-49.08,;174.48,-54.82,;159.65,-92.54,;149.73,-98.23,;149.72,-109.76,;159.65,-115.58,;169.68,-109.71,;169.64,-98.21,;179.64,-92.45,;190.06,-97.09,;197.69,-88.48,;191.93,-78.57,;180.68,-81.01,;191.82,-67.1,;202.97,-75.54,)|</extended-smiles>
<aux-info>AuxInfo=1/0/N:20,21,11,12,10,13,1,5,2,4,7,17,6,3,9,14,15,18,19,8,16/E:(1,2)(7,8)(9,10)/rA:21nCCCCCCCOCCCCCCCOCCNCC/rB:d1;s2;d3;s4;s1d5;s6;d7;s3;d9;s10;d11;s12;s9d13;s14;s15;s16;s17;d15s18;s18;s18;/rC:149,7649,-63,5195,0;149,7429,-75,1873,0;159,6582,-81,0057,0;169,6844,-75,1782,0;169,6298,-63,4501,0;159,6237,-57,7827,0;164,5512,-49,0847,0;174,4844,-54,8197,0;159,6544,-92,5417,0;149,7300,-98,2301,0;149,7213,-109,7554,0;159,6484,-115,5780,0;169,6844,-109,7121,0;169,6441,-98,2057,0;179,6351,-92,4453,0;190,0571,-97,0878,0;197,6886,-88,4780,0;191,9278,-78,5659,0;180,6763,-81,0098,0;191,8246,-67,1026,0;202,9696,-75,5409,0;</aux-info>
<molecular-formula>C18H17NO2</molecular-formula>
<abbreviations>C(=O)* CHO</abbreviations>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 21 23 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 149.76491 -63.51952 0 0
M  V30 2 C 149.74287 -75.18733 0 0
M  V30 3 C 159.6582 -81.00574 0 0
M  V30 4 C 169.6844 -75.17819 0 0
M  V30 5 C 169.62982 -63.45006 0 0
M  V30 6 C 159.62373 -57.7827 0 0
M  V30 7 C 164.55116 -49.08469 0 0
M  V30 8 O 174.48442 -54.81966 0 0
M  V30 9 C 159.65437 -92.5417 0 0
M  V30 10 C 149.73004 -98.23013 0 0
M  V30 11 C 149.72133 -109.75543 0 0
M  V30 12 C 159.64839 -115.57805 0 0
M  V30 13 C 169.68436 -109.71205 0 0
M  V30 14 C 169.64412 -98.20567 0 0
M  V30 15 C 179.63509 -92.44534 0 0
M  V30 16 O 190.05714 -97.08784 0 0
M  V30 17 C 197.68861 -88.478 0 0
M  V30 18 C 191.92783 -78.56595 0 0
M  V30 19 N 180.6763 -81.0098 0 0
M  V30 20 C 191.82463 -67.10255 0 0
M  V30 21 C 202.96956 -75.54086 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 4
M  V30 4 1 4 5
M  V30 5 2 5 6
M  V30 6 1 6 1
M  V30 7 2 7 8
M  V30 8 1 6 7
M  V30 9 1 3 9
M  V30 10 2 9 10
M  V30 11 1 10 11
M  V30 12 2 11 12
M  V30 13 1 12 13
M  V30 14 2 13 14
M  V30 15 1 14 9
M  V30 16 1 14 15
M  V30 17 1 15 16
M  V30 18 1 16 17
M  V30 19 1 17 18
M  V30 20 1 18 19
M  V30 21 2 19 15
M  V30 22 1 18 20
M  V30 23 1 18 21
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i2" left="149.4661" right="203.03696" top="42.448166" bottom="115.87367"/>
<backref ref="1860-5397-6-25-i3" left="162.67982" right="216.6191" top="65.41403" bottom="139.32593"/>
</substance>
<substance id="1860-5397-6-25-VXWBQOJISHAKKM-UHFFFAOYSA-N">
<inchi-key>VXWBQOJISHAKKM-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C7H7BO3/c9-5-6-1-3-7(4-2-6)8(10)11/h1-5,10-11H</inchi>
<smiles>C1=C(C=CC(=C1)B(O)O)C=O</smiles>
<extended-smiles>C1=CC(=CC=C1C=O)B(O)O |(10.78,-78.33,;10.78,-89.84,;20.75,-95.6,;30.72,-89.84,;30.72,-78.33,;20.75,-72.58,;25.72,-63.98,;35.65,-69.71,;20.75,-107.06,;30.68,-112.8,;10.82,-112.8,)|</extended-smiles>
<aux-info>AuxInfo=1/0/N:1,5,2,4,7,6,3,9,8,10,11/E:(1,2)(3,4)(10,11)/rA:11nCCCCCCCOBOO/rB:d1;s2;d3;s4;s1d5;s6;d7;s3;s9;s9;/rC:10,7823,-78,3321,0;10,7823,-89,8407,0;20,7491,-95,5950,0;30,7159,-89,8407,0;30,7159,-78,3321,0;20,7491,-72,5777,0;25,7157,-63,9753,0;35,6490,-69,7103,0;20,7491,-107,0649,0;30,6824,-112,7999,0;10,8159,-112,7999,0;</aux-info>
<molecular-formula>C7H7BO3</molecular-formula>
<abbreviations>C(=O)* CHO</abbreviations>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 11 11 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 10.78233 -78.33206 0 0
M  V30 2 C 10.78233 -89.8407 0 0
M  V30 3 C 20.74911 -95.59502 0 0
M  V30 4 C 30.7159 -89.8407 0 0
M  V30 5 C 30.7159 -78.33206 0 0
M  V30 6 C 20.74911 -72.57774 0 0
M  V30 7 C 25.71573 -63.97528 0 0
M  V30 8 O 35.64899 -69.71025 0 0
M  V30 9 B 20.74911 -107.06494 0 0
M  V30 10 O 30.68236 -112.79991 0 0
M  V30 11 O 10.81586 -112.79991 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 4
M  V30 4 1 4 5
M  V30 5 2 5 6
M  V30 6 1 6 1
M  V30 7 2 7 8
M  V30 8 1 6 7
M  V30 9 1 3 9
M  V30 10 1 9 10
M  V30 11 1 9 11
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i2" left="1.9908447" right="39.507355" top="57.31613" bottom="115.87491"/>
</substance>
<substance id="1860-5397-6-25-XLCYXINIUJNTPF-UHFFFAOYSA-N">
<inchi-key>XLCYXINIUJNTPF-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C11H12BrNO/c1-11(2)7-14-10(13-11)8-5-3-4-6-9(8)12/h3-6H,7H2,1-2H3</inchi>
<smiles>CC1(C)COC(=N1)C2=C(C=CC=C2)Br</smiles>
<extended-smiles>C1=CC=CC(=C1Br)C=2OCC(N2)(C)C |(57.22,-78.34,;57.18,-89.97,;67.13,-95.8,;77.2,-89.97,;77.16,-78.26,;67.13,-72.59,;67.05,-61,;87.19,-72.46,;97.78,-77.18,;105.49,-68.59,;99.7,-58.56,;88.39,-61,;99.62,-47.01,;109.61,-52.68,)|</extended-smiles>
<aux-info>AuxInfo=1/0/N:13,14,3,2,4,1,10,5,6,8,11,7,12,9/E:(1,2)/rA:14nCCCCCCBrCOCCNCC/rB:d1;s2;d3;s4;s1d5;s6;s5;s8;s9;s10;d8s11;s11;s11;/rC:57,2183,-78,3394,0;57,1777,-89,9698,0;67,1284,-95,8022,0;77,2008,-89,9698,0;77,1602,-78,2582,0;67,1284,-72,5851,0;67,0472,-60,9952,0;87,1920,-72,4633,0;97,7827,-77,1810,0;105,4947,-68,5886,0;99,6998,-58,5567,0;88,3910,-60,9952,0;99,6186,-47,0075,0;109,6098,-52,6807,0;</aux-info>
<molecular-formula>C11H12BrNO</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 14 15 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 57.21834 -78.33939 0 0
M  V30 2 C 57.17775 -89.9698 0 0
M  V30 3 C 67.12839 -95.80217 0 0
M  V30 4 C 77.20079 -89.9698 0 0
M  V30 5 C 77.16019 -78.25821 0 0
M  V30 6 C 67.12839 -72.58507 0 0
M  V30 7 Br 67.04721 -60.99524 0 0
M  V30 8 C 87.19202 -72.46329 0 0
M  V30 9 O 97.78273 -77.18103 0 0
M  V30 10 C 105.49471 -68.58858 0 0
M  V30 11 C 99.69978 -58.55675 0 0
M  V30 12 N 88.39098 -60.99524 0 0
M  V30 13 C 99.61861 -47.00752 0 0
M  V30 14 C 109.60982 -52.68066 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 4
M  V30 4 1 4 5
M  V30 5 2 5 6
M  V30 6 1 1 6
M  V30 7 1 6 7
M  V30 8 1 5 8
M  V30 9 1 8 9
M  V30 10 1 9 10
M  V30 11 1 10 11
M  V30 12 1 11 12
M  V30 13 2 8 12
M  V30 14 1 11 13
M  V30 15 1 11 14
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i2" left="56.92212" right="109.73993" top="47.005722" bottom="96.09741"/>
</substance>
<substance id="1860-5397-6-25-HLOKZJWEQPVFFJ-UHFFFAOYSA-N">
<inchi-key>HLOKZJWEQPVFFJ-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C19H22N4O/c1-4-7-17(24)22-18-12(2)10-13(11-14(18)20)19-21-15-8-5-6-9-16(15)23(19)3/h5-6,8-11H,4,7,20H2,1-3H3,(H,22,24)</inchi>
<smiles>CCCC(=O)NC1=C(C=C(C=C1C)C2=NC3=CC=CC=C3N2C)N</smiles>
<extended-smiles>C1=CC=C2C(=C1)N=C(N2C)C3=CC(=C(C(=C3)C)NC(CCC)=O)N |(27.49,-99.92,;27.47,-111.59,;37.53,-117.37,;47.58,-111.57,;47.57,-99.85,;37.5,-94.15,;58.67,-96.28,;65.57,-105.75,;58.68,-115.14,;58.53,-126.69,;77.05,-105.7,;82.87,-115.71,;94.33,-115.66,;100.2,-105.64,;94.25,-95.62,;82.74,-95.73,;100.01,-85.51,;111.42,-108.1,;119.21,-99.56,;130.49,-102.03,;138.28,-93.49,;149.56,-95.96,;115.71,-88.55,;102.05,-124.23,)|</extended-smiles>
<aux-info>AuxInfo=1/1/N:24,19,10,23,1,2,21,4,3,14,12,13,11,17,8,9,20,16,6,18,7,15,5,22/rA:24nCCCCNCNCCCCCCCNCCNCCCOCC/rB:d1;s2;s1;;s5;d6;d4s7;d3s5s8;s5;s6;d11;;s11d13;;s13s15;s12d16;s17;s13;s15;s20;d20;s21;s23;/rC:27,4950,-99,9248,0;27,4728,-111,5898,0;37,5340,-117,3666,0;37,4993,-94,1501,0;58,6765,-115,1390,0;65,5732,-105,7455,0;58,6674,-96,2781,0;47,5716,-99,8550,0;47,5767,-111,5741,0;58,5344,-126,6903,0;77,0454,-105,6952,0;82,8694,-115,7113,0;94,2509,-95,6192,0;82,7396,-95,7300,0;111,4246,-108,0951,0;100,1957,-105,6358,0;94,3316,-115,6572,0;102,0517,-124,2307,0;100,0083,-85,5116,0;119,2079,-99,5575,0;130,4934,-102,0293,0;115,7058,-88,5481,0;138,2768,-93,4917,0;149,5622,-95,9634,0;</aux-info>
<molecular-formula>C19H22N4O</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 24 26 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 27.49498 -99.92484 0 0
M  V30 2 C 27.47279 -111.58981 0 0
M  V30 3 C 37.53397 -117.36662 0 0
M  V30 4 C 37.49925 -94.15005 0 0
M  V30 5 N 58.67647 -115.13898 0 0
M  V30 6 C 65.57315 -105.74545 0 0
M  V30 7 N 58.66739 -96.27808 0 0
M  V30 8 C 47.57161 -99.85497 0 0
M  V30 9 C 47.57668 -111.57405 0 0
M  V30 10 C 58.53441 -126.69034 0 0
M  V30 11 C 77.04536 -105.69524 0 0
M  V30 12 C 82.86945 -115.71129 0 0
M  V30 13 C 94.2509 -95.61919 0 0
M  V30 14 C 82.73956 -95.73004 0 0
M  V30 15 N 111.42456 -108.09514 0 0
M  V30 16 C 100.19566 -105.63576 0 0
M  V30 17 C 94.33162 -115.65721 0 0
M  V30 18 N 102.05173 -124.23065 0 0
M  V30 19 C 100.00835 -85.51161 0 0
M  V30 20 C 119.20793 -99.55751 0 0
M  V30 21 C 130.49341 -102.02928 0 0
M  V30 22 O 115.7058 -88.5481 0 0
M  V30 23 C 138.27676 -93.49167 0 0
M  V30 24 C 149.56224 -95.96342 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 9
M  V30 4 2 8 4
M  V30 5 1 4 1
M  V30 6 1 8 9
M  V30 7 2 6 7
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 9 5
M  V30 11 1 5 10
M  V30 12 1 6 11
M  V30 13 2 11 12
M  V30 14 1 12 17
M  V30 15 1 16 13
M  V30 16 2 13 14
M  V30 17 1 14 11
M  V30 18 2 16 17
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 13 19
M  V30 22 1 15 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i3" left="27.231033" right="149.6139" top="84.756424" bottom="128.83064"/>
</substance>
<substance id="1860-5397-6-25-KCGLCZNSSVOXKO-UHFFFAOYSA-N">
<inchi-key>KCGLCZNSSVOXKO-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C37H37N5O/c1-6-11-33-39-34-24(2)20-27(35-38-30-14-9-10-15-31(30)41(35)5)21-32(34)42(33)22-25-16-18-26(19-17-25)28-12-7-8-13-29(28)36-40-37(3,4)23-43-36/h7-10,12-21H,6,11,22-23H2,1-5H3</inchi>
<smiles>CCCC1=NC2=C(C=C(C=C2C)C3=NC4=C(C=CC=C4)N3C)N1CC5=CC=C(C=C5)C6=C(C=CC=C6)C7=NC(C)(C)CO7</smiles>
<extended-smiles>C1=CC=C2C(=C1)N=C(N2C)C3=CC4=C(C(=C3)C)N=C(CCC)N4CC5=CC=C(C=C5)C6=CC=CC=C6C7=NC(CO7)(C)C |(87.57,-207.67,;87.55,-219.39,;97.67,-225.23,;107.77,-219.37,;107.76,-207.6,;97.63,-201.91,;118.91,-204.04,;125.88,-213.56,;118.92,-223.01,;118.78,-234.61,;137.4,-213.51,;143.21,-223.58,;154.73,-223.53,;160.65,-213.45,;154.64,-203.38,;143.08,-203.49,;160.47,-193.22,;171.94,-215.9,;173.18,-227.38,;183.29,-233.29,;183.31,-244.88,;193.42,-250.7,;162.51,-232.08,;160.11,-243.38,;150.09,-249.16,;140.08,-243.38,;130.07,-249.16,;130.07,-260.73,;140.08,-266.51,;150.09,-260.73,;120.06,-266.51,;110.02,-260.71,;99.98,-266.51,;99.98,-278.1,;110.02,-283.89,;120.06,-278.1,;130.06,-283.87,;131.27,-295.4,;142.61,-297.81,;148.41,-287.77,;140.65,-279.16,;147.31,-308.37,;154.15,-298.42,)|</extended-smiles>
<aux-info>AuxInfo=1/0/N:23,20,42,43,10,22,33,34,1,2,21,32,35,4,3,26,30,27,29,14,12,24,40,13,25,28,11,31,36,8,9,17,19,16,6,37,39,7,15,38,5,18,41/E:(3,4)(16,17)(18,19)/rA:43nCCCCNCNCCCCCCCNCCNCCCCCCCCCCCCCCCCCCCNCCOCC/rB:d1;s2;s1;;s5;d6;d4s7;d3s5s8;s5;s6;d11;;s11d13;;s13s15;s12d16;s17;d15s18;s13;s19;s21;s22;s18;s24;d25;s26;d27;s28;s25d29;s28;d31;s32;d33;s34;s31d35;s36;d37;s38;s39;s37s40;s39;s39;/rC:87,5748,-207,6728,0;87,5526,-219,3888,0;97,6688,-225,2312,0;97,6341,-201,9123,0;118,9188,-223,0091,0;125,8783,-213,5589,0;118,9097,-204,0350,0;107,7615,-207,6031,0;107,7665,-219,3730,0;118,7771,-234,6118,0;137,4020,-213,5088,0;143,2117,-223,5800,0;154,6449,-203,3778,0;143,0821,-203,4884,0;171,9359,-215,9028,0;160,6548,-213,4494,0;154,7255,-223,5260,0;162,5063,-232,0782,0;173,1786,-227,3843,0;160,4680,-193,2153,0;183,2946,-233,2889,0;183,3069,-244,8795,0;193,4227,-250,7042,0;160,1073,-243,3826,0;150,0932,-249,1643,0;140,0791,-243,3826,0;130,0650,-249,1643,0;130,0650,-260,7275,0;140,0791,-266,5092,0;150,0932,-260,7275,0;120,0571,-266,5056,0;110,0181,-260,7097,0;99,9791,-266,5056,0;99,9791,-278,0977,0;110,0181,-283,8936,0;120,0571,-278,0977,0;130,0612,-283,8735,0;131,2729,-295,4020,0;142,6116,-297,8121,0;148,4075,-287,7731,0;140,6510,-279,1586,0;147,3101,-308,3652,0;154,1475,-298,4167,0;</aux-info>
<molecular-formula>C37H37N5O</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 43 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 87.57477 -207.67276 0 0
M  V30 2 C 87.5526 -219.38878 0 0
M  V30 3 C 97.66879 -225.23122 0 0
M  V30 4 C 97.63414 -201.91229 0 0
M  V30 5 N 118.91879 -223.00912 0 0
M  V30 6 C 125.87833 -213.55891 0 0
M  V30 7 N 118.90973 -204.03502 0 0
M  V30 8 C 107.76152 -207.60306 0 0
M  V30 9 C 107.76654 -219.37303 0 0
M  V30 10 C 118.7771 -234.61177 0 0
M  V30 11 C 137.40204 -213.50879 0 0
M  V30 12 C 143.21173 -223.57999 0 0
M  V30 13 C 154.6449 -203.37778 0 0
M  V30 14 C 143.08212 -203.48837 0 0
M  V30 15 N 171.93587 -215.90277 0 0
M  V30 16 C 160.65485 -213.44945 0 0
M  V30 17 C 154.72546 -223.52602 0 0
M  V30 18 N 162.50632 -232.07822 0 0
M  V30 19 C 173.17865 -227.38432 0 0
M  V30 20 C 160.46805 -193.21532 0 0
M  V30 21 C 183.29456 -233.28891 0 0
M  V30 22 C 183.30685 -244.8795 0 0
M  V30 23 C 193.42267 -250.70418 0 0
M  V30 24 C 160.10728 -243.38264 0 0
M  V30 25 C 150.09319 -249.16428 0 0
M  V30 26 C 140.0791 -243.38264 0 0
M  V30 27 C 130.065 -249.16428 0 0
M  V30 28 C 130.065 -260.72754 0 0
M  V30 29 C 140.0791 -266.50919 0 0
M  V30 30 C 150.09319 -260.72754 0 0
M  V30 31 C 120.05707 -266.50565 0 0
M  V30 32 C 110.0181 -260.70966 0 0
M  V30 33 C 99.97914 -266.50565 0 0
M  V30 34 C 99.97914 -278.09766 0 0
M  V30 35 C 110.0181 -283.89362 0 0
M  V30 36 C 120.05707 -278.09766 0 0
M  V30 37 C 130.06117 -283.8735 0 0
M  V30 38 N 131.27287 -295.40198 0 0
M  V30 39 C 142.61156 -297.8121 0 0
M  V30 40 C 148.40755 -287.77313 0 0
M  V30 41 O 140.65099 -279.15863 0 0
M  V30 42 C 147.31009 -308.36517 0 0
M  V30 43 C 154.14749 -298.41669 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 9
M  V30 4 2 8 4
M  V30 5 1 4 1
M  V30 6 1 8 9
M  V30 7 2 6 7
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 9 5
M  V30 11 1 5 10
M  V30 12 1 6 11
M  V30 13 2 11 12
M  V30 14 1 12 17
M  V30 15 1 16 13
M  V30 16 2 13 14
M  V30 17 1 14 11
M  V30 18 2 16 17
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 2 19 15
M  V30 22 1 13 20
M  V30 23 1 19 21
M  V30 24 1 21 22
M  V30 25 1 22 23
M  V30 26 1 18 19
M  V30 27 1 18 24
M  V30 28 1 24 25
M  V30 29 2 25 26
M  V30 30 1 26 27
M  V30 31 2 27 28
M  V30 32 1 28 29
M  V30 33 2 29 30
M  V30 34 1 30 25
M  V30 35 1 28 31
M  V30 36 2 31 32
M  V30 37 1 32 33
M  V30 38 2 33 34
M  V30 39 1 34 35
M  V30 40 2 35 36
M  V30 41 1 36 31
M  V30 42 1 36 37
M  V30 43 2 37 38
M  V30 44 1 38 39
M  V30 45 1 39 40
M  V30 46 1 40 41
M  V30 47 1 41 37
M  V30 48 1 39 42
M  V30 49 1 39 43
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i3" left="87.31084" right="193.54317" top="193.09525" bottom="308.46338"/>
</substance>
<substance id="1860-5397-6-25-KJLBCXGNOGWOBT-UHFFFAOYSA-N">
<inchi-key>KJLBCXGNOGWOBT-UHFFFAOYSA-N</inchi-key>
<inchi>InChI=1S/C37H39N5O2/c1-6-11-33(43)40-34-24(2)20-27(35-39-30-14-9-10-15-32(30)42(35)5)21-31(34)38-22-25-16-18-26(19-17-25)28-12-7-8-13-29(28)36-41-37(3,4)23-44-36/h7-10,12-21,38H,6,11,22-23H2,1-5H3,(H,40,43)</inchi>
<smiles>CCCC(=O)NC1=C(C=C(C=C1C)C2=NC3=CC=CC=C3N2C)NCC4=CC=C(C=C4)C5=C(C=CC=C5)C6=NC(C)(C)CO6</smiles>
<extended-smiles>C1=CC=C2C(=C1)N=C(N2C)C3=CC(=C(C(=C3)C)NC(CCC)=O)NCC4=CC=C(C=C4)C5=CC=CC=C5C6=NC(CO6)(C)C |(277.08,-68.85,;277.06,-80.6,;287.2,-86.46,;297.32,-80.58,;297.32,-68.78,;287.17,-63.08,;308.49,-65.21,;315.48,-74.76,;308.5,-84.23,;308.36,-95.86,;327.03,-74.7,;332.86,-84.8,;344.4,-84.75,;350.34,-74.65,;344.32,-64.55,;332.73,-64.66,;350.16,-54.36,;361.65,-77.1,;369.42,-68.56,;380.71,-71.01,;388.48,-62.46,;399.77,-64.92,;365.9,-57.55,;352.2,-93.32,;352.2,-104.91,;342.16,-110.71,;332.12,-104.91,;322.08,-110.71,;322.08,-122.3,;332.12,-128.1,;342.16,-122.3,;312.08,-128.08,;302.04,-122.28,;292,-128.08,;292,-139.67,;302.04,-145.46,;312.08,-139.67,;322.08,-145.44,;323.29,-156.97,;334.63,-159.38,;340.43,-149.34,;332.67,-140.73,;339.33,-169.94,;346.17,-159.99,)|</extended-smiles>
<aux-info>AuxInfo=1/1/N:24,19,43,44,10,23,34,35,1,2,21,33,36,4,3,27,31,28,30,14,12,25,41,13,26,29,11,32,37,8,17,9,20,16,6,38,40,18,7,15,39,5,22,42/E:(3,4)(16,17)(18,19)/rA:44nCCCCNCNCCCCCCCNCCNCCCOCCCCCCCCCCCCCCCCNCCOCC/rB:d1;s2;s1;;s5;d6;d4s7;d3s5s8;s5;s6;d11;;s11d13;;s13s15;s12d16;s17;s13;s15;s20;d20;s21;s23;s18;s25;d26;s27;d28;s29;s26d30;s29;d32;s33;d34;s35;s32d36;s37;d38;s39;s40;s38s41;s40;s40;/rC:277,0815,-68,8544,0;277,0593,-80,5995,0;287,2006,-86,4565,0;287,1659,-63,0796,0;308,5034,-84,2289,0;315,4802,-74,7552,0;308,4943,-65,2076,0;297,3184,-68,7845,0;297,3234,-80,5838,0;308,3613,-95,8603,0;327,0325,-74,7049,0;332,8566,-84,8011,0;344,3182,-64,5488,0;332,7267,-64,6596,0;361,6521,-77,1049,0;350,3431,-74,6455,0;344,3989,-84,7471,0;352,1992,-93,3205,0;350,1558,-54,3611,0;369,4229,-68,5557,0;380,7119,-71,0108,0;365,9044,-57,5515,0;388,4827,-62,4617,0;399,7718,-64,9167,0;352,1992,-104,9125,0;342,1602,-110,7085,0;332,1212,-104,9125,0;322,0823,-110,7085,0;322,0823,-122,3005,0;332,1212,-128,0965,0;342,1602,-122,3005,0;312,0782,-128,0763,0;302,0392,-122,2803,0;292,0002,-128,0763,0;292,0002,-139,6683,0;302,0392,-145,4643,0;312,0782,-139,6683,0;322,0823,-145,4442,0;323,2939,-156,9727,0;334,6326,-159,3828,0;340,4286,-149,3439,0;332,6721,-140,7293,0;339,3312,-169,9359,0;346,1686,-159,9874,0;</aux-info>
<molecular-formula>C37H39N5O2</molecular-formula>
<molfile>
  CDK     04222607282D

  0  0  0     0  0            999 V3000
M  V30 BEGIN CTAB
M  V30 COUNTS 44 49 0 0 0
M  V30 BEGIN ATOM
M  V30 1 C 277.08148 -68.85443 0 0
M  V30 2 C 277.05927 -80.59953 0 0
M  V30 3 C 287.20059 -86.45648 0 0
M  V30 4 C 287.16586 -63.07964 0 0
M  V30 5 N 308.50336 -84.22887 0 0
M  V30 6 C 315.48016 -74.75519 0 0
M  V30 7 N 308.49426 -65.20764 0 0
M  V30 8 C 297.31836 -68.78455 0 0
M  V30 9 C 297.32343 -80.58377 0 0
M  V30 10 C 308.3613 -95.86034 0 0
M  V30 11 C 327.03253 -74.70493 0 0
M  V30 12 C 332.8566 -84.80115 0 0
M  V30 13 C 344.31818 -64.54877 0 0
M  V30 14 C 332.72672 -64.65964 0 0
M  V30 15 N 361.6521 -77.10486 0 0
M  V30 16 C 350.34308 -74.64546 0 0
M  V30 17 C 344.39893 -84.74707 0 0
M  V30 18 N 352.19916 -93.32048 0 0
M  V30 19 C 350.15579 -54.36105 0 0
M  V30 20 C 369.42285 -68.55574 0 0
M  V30 21 C 380.71194 -71.01082 0 0
M  V30 22 O 365.90442 -57.55153 0 0
M  V30 23 C 388.48267 -62.46169 0 0
M  V30 24 C 399.77182 -64.91675 0 0
M  V30 25 C 352.19916 -104.91248 0 0
M  V30 26 C 342.16019 -110.70848 0 0
M  V30 27 C 332.12122 -104.91248 0 0
M  V30 28 C 322.08228 -110.70848 0 0
M  V30 29 C 322.08228 -122.30048 0 0
M  V30 30 C 332.12122 -128.09647 0 0
M  V30 31 C 342.16019 -122.30048 0 0
M  V30 32 C 312.07816 -128.07634 0 0
M  V30 33 C 302.03918 -122.28035 0 0
M  V30 34 C 292.00024 -128.07634 0 0
M  V30 35 C 292.00024 -139.66833 0 0
M  V30 36 C 302.03918 -145.46434 0 0
M  V30 37 C 312.07816 -139.66833 0 0
M  V30 38 C 322.08228 -145.44421 0 0
M  V30 39 N 323.29395 -156.9727 0 0
M  V30 40 C 334.63263 -159.38283 0 0
M  V30 41 C 340.42865 -149.34386 0 0
M  V30 42 O 332.67209 -140.72932 0 0
M  V30 43 C 339.33118 -169.93587 0 0
M  V30 44 C 346.16858 -159.9874 0 0
M  V30 END ATOM
M  V30 BEGIN BOND
M  V30 1 2 1 2
M  V30 2 1 2 3
M  V30 3 2 3 9
M  V30 4 2 8 4
M  V30 5 1 4 1
M  V30 6 1 8 9
M  V30 7 2 6 7
M  V30 8 1 5 6
M  V30 9 1 7 8
M  V30 10 1 9 5
M  V30 11 1 5 10
M  V30 12 1 6 11
M  V30 13 2 11 12
M  V30 14 1 12 17
M  V30 15 1 16 13
M  V30 16 2 13 14
M  V30 17 1 14 11
M  V30 18 2 16 17
M  V30 19 1 15 16
M  V30 20 1 17 18
M  V30 21 1 13 19
M  V30 22 1 15 20
M  V30 23 1 20 21
M  V30 24 2 20 22
M  V30 25 1 21 23
M  V30 26 1 23 24
M  V30 27 1 18 25
M  V30 28 1 25 26
M  V30 29 2 26 27
M  V30 30 1 27 28
M  V30 31 2 28 29
M  V30 32 1 29 30
M  V30 33 2 30 31
M  V30 34 1 31 26
M  V30 35 1 29 32
M  V30 36 2 32 33
M  V30 37 1 33 34
M  V30 38 2 34 35
M  V30 39 1 35 36
M  V30 40 2 36 37
M  V30 41 1 37 32
M  V30 42 1 37 38
M  V30 43 2 38 39
M  V30 44 1 39 40
M  V30 45 1 40 41
M  V30 46 1 41 42
M  V30 47 1 42 38
M  V30 48 1 40 43
M  V30 49 1 40 44
M  V30 END BOND
M  V30 END CTAB
M  END
</molfile>
<backref ref="1860-5397-6-25-i3" left="276.8175" right="399.82315" top="53.759857" bottom="170.03409"/>
</substance>
</substances>
<end-section>
<title>
<chunk>Acknowledgements</chunk>
</title>
<paragraph>
<chunk>We are grateful to SVNIT, Surat and IICT, Hyderabad for supporting this work.</chunk>
</paragraph>
</end-section>
<reference id="b1" type="article" volume="66" issue="1" first-page="51" last-page="83">
<reference-author given-names="A. J." last-name="Battershill"/>
<reference-author given-names="L. J." last-name="Scott"/>
<source>
<chunk>Drugs</chunk>
</source>
<publication-date year="2006"/>
</reference>
<reference id="b2" type="patent" patent-number=" 5,591,762">
<reference-author given-names="N." last-name="Hauel"/>
<reference-author given-names="B." last-name="Narr"/>
<reference-author given-names="U." last-name="Ries"/>
<reference-author given-names="J. C. A." last-name="van Meel"/>
<reference-author given-names="W." last-name="Wienen"/>
<reference-author given-names="M." last-name="Entzeroth"/>
<title>
<chunk>Benzimidazoles useful as angiotensin-11 antagonists</chunk>
</title>
<source>
<chunk>U.S. Patent</chunk>
</source>
<publication-date day="7" month="1" year="1997"/>
</reference>
<reference id="b3" type="article" volume="39" first-page="625" last-page="656">
<reference-author given-names="R. R." last-name="Wexler"/>
<reference-author given-names="W. J." last-name="Greenlee"/>
<reference-author given-names="J. D." last-name="Irvin"/>
<reference-author given-names="M. R." last-name="Goldberg"/>
<reference-author given-names="K." last-name="Prendergast"/>
<reference-author given-names="R. D." last-name="Smith"/>
<reference-author given-names="P. B. M. W. M." last-name="Timmermans"/>
<source>
<chunk>J. Med. Chem.</chunk>
</source>
<publication-date year="1996"/>
<external-link type="doi" public-id="10.1021/jm9504722"/>
</reference>
<reference id="b4" type="url">
<external-link type="uri" public-id="http://www.rxlist.com/cgi/generic2/telmisartan.htm"/>
</reference>
<reference id="b5" type="article" volume="36" first-page="4040" last-page="4051">
<reference-author given-names="U. J." last-name="Ries"/>
<reference-author given-names="G." last-name="Mihm"/>
<reference-author given-names="B." last-name="Narr"/>
<reference-author given-names="K. M." last-name="Hasselbach"/>
<reference-author given-names="H." last-name="Wittneben"/>
<reference-author given-names="M." last-name="Entzeroth"/>
<reference-author given-names="J. C. A." last-name="van Meel"/>
<reference-author given-names="W." last-name="Wienen"/>
<reference-author given-names="N. H." last-name="Hauel"/>
<source>
<chunk>J. Med. Chem.</chunk>
</source>
<publication-date year="1993"/>
<external-link type="doi" public-id="10.1021/jm00077a007"/>
</reference>
<reference id="b6" type="article" volume="11" first-page="81" last-page="85">
<reference-author given-names="K. S." last-name="Reddy"/>
<reference-author given-names="N." last-name="Srinivasan"/>
<reference-author given-names="C. R." last-name="Reddy"/>
<reference-author given-names="N." last-name="Kolla"/>
<reference-author given-names="Y." last-name="Anjaneyulu"/>
<reference-author given-names="S." last-name="Venkatraman"/>
<reference-author given-names="A." last-name="Bhattacharya"/>
<reference-author given-names="V. T." last-name="Mathad"/>
<source>
<chunk>Org. Process Res. Dev.</chunk>
</source>
<publication-date year="2007"/>
<external-link type="doi" public-id="10.1021/op060200g"/>
</reference>
<reference id="b7" type="article" volume="34" first-page="2525" last-page="2547">
<reference-author given-names="D. J." last-name="Carini"/>
<reference-author given-names="J. V." last-name="Duncia"/>
<reference-author given-names="P. E." last-name="Aldrich"/>
<reference-author given-names="A. T." last-name="Chiu"/>
<reference-author given-names="A. L." last-name="Johnson"/>
<reference-author given-names="M. E." last-name="Pierce"/>
<reference-author given-names="W. A." last-name="Price"/>
<reference-author given-names="J. B." last-name="Santella" suffix="III"/>
<reference-author given-names="G. J." last-name="Wells"/>
<reference-author given-names="R. R." last-name="Wexler"/>
<reference-author given-names="P. C." last-name="Wong"/>
<reference-author given-names="S.-E." last-name="Yoo"/>
<reference-author given-names="P. B. W. M." last-name="Timmermans"/>
<source>
<chunk>J. Med. Chem.</chunk>
</source>
<publication-date year="1991"/>
<external-link type="doi" public-id="10.1021/jm00112a031"/>
</reference>
<reference id="b8" type="patent" patent-number="DE19632643C1">
<reference-author given-names="B." last-name="Kohler"/>
<reference-author given-names="M." last-name="Langer"/>
<reference-author given-names="T." last-name="Mosandl"/>
<title>
<chunk>Catalyzed Coupling of Aryl magnesium halides and Bromo aryl carbon Acidic Compounds to the Production of Biphenyl Carboxlic Acid</chunk>
</title>
<source>
<chunk>Ger. Pat. Appl.</chunk>
</source>
<publication-date day="22" month="1" year="1998"/>
</reference>
<reference id="b9" type="article" volume="390" first-page="389" last-page="398">
<reference-author given-names="C." last-name="Amatore"/>
<reference-author given-names="A." last-name="Jutand"/>
<reference-author given-names="S." last-name="Negri"/>
<source>
<chunk>J. Organomet. Chem.</chunk>
</source>
<publication-date year="1990"/>
<external-link type="doi" public-id="10.1016/0022-328X(90)85107-A"/>
</reference>
<reference id="b10" type="article" volume="26" first-page="5997" last-page="6000">
<reference-author given-names="M. J." last-name="Sharp"/>
<reference-author given-names="V." last-name="Snieckus"/>
<source>
<chunk>Tetrahedron Lett.</chunk>
</source>
<publication-date year="1985"/>
<external-link type="doi" public-id="10.1016/S0040-4039(00)95108-6"/>
</reference>
<reference id="b11" type="patent" patent-number="WO 2006/103068A1">
<reference-author given-names="A." last-name="Copar"/>
<reference-author given-names="L." last-name="Antoncic"/>
<reference-author given-names="M. T." last-name="Antoncic"/>
<title>
<chunk>A Synthesis of 4-Bromomethyl-2&#8217;-Formylbiphenyl and 4-Bromomethyl-2&#8217;-Hydroxymethyl biphenyl and Its Use in Preparation of Angiotensin II Antagonists</chunk>
</title>
<source>
<chunk>Int. Pat. Appl.</chunk>
</source>
<publication-date year="2006"/>
</reference>
<reference id="b12" type="article" volume="41" first-page="837" last-page="860">
<reference-author given-names="M." last-name="Reuman"/>
<reference-author given-names="A. I." last-name="Meyers"/>
<source>
<chunk>Tetrahedron</chunk>
</source>
<publication-date year="1985"/>
<external-link type="doi" public-id="10.1016/S0040-4020(01)96401-4"/>
</reference>
<reference id="b13" type="article" volume="73" first-page="8631" last-page="8634">
<reference-author given-names="L. J." last-name="Goossen"/>
<reference-author given-names="T." last-name="Knaubar"/>
<source>
<chunk>J. Org. Chem.</chunk>
</source>
<publication-date year="2008"/>
<external-link type="doi" public-id="10.1021/jo801937h"/>
</reference>
<copyright year="2010" holder="Kumar et al; licensee Beilstein-Institut." link="http://creativecommons.org/licenses/by/2.0">
<paragraph>
<chunk>This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</chunk>
</paragraph>
<paragraph>
<chunk>The license is subject to the </chunk>
<chunk italic="yes">Beilstein Journal of Organic Chemistry</chunk>
<chunk> terms and conditions: (http://www.beilstein-journals.org/bjoc)</chunk>
</paragraph>
</copyright>
</article>
